fibrinogen has been researched along with Recrudescence in 217 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 68 (31.34) | 18.7374 |
| 1990's | 60 (27.65) | 18.2507 |
| 2000's | 50 (23.04) | 29.6817 |
| 2010's | 32 (14.75) | 24.3611 |
| 2020's | 7 (3.23) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y; Chen, H; Dong, W; Gu, W; Guo, Y; Liu, Y; Shang, L; Yang, H; Yang, X; Yue, Y; Zhang, X | 1 |
| Zhang, K; Zhu, L | 1 |
| Asselta, R; Caccia, S; Kubisz, P; Lasabova, Z; Loderer, D; Simurda, T; Skornova, I; Snahnicanova, Z; Stasko, J; Zolkova, J | 1 |
| Assari, R; Ebadi, F; Mirmohammadsadeghi, A; Sadeghi, P; Ziaee, V | 1 |
| Eriksson, H; Heikkilä, HM; Ijäs, P; Koskinen, S; Kovanen, PT; Lindsberg, PJ; Mäyränpää, MI; Nuotio, K; Silvennoinen, H; Soinne, L; Valanne, L; Vikatmaa, P | 1 |
| Gemra, M; Iwaszko, A; Kozdrowski, R; Pliszczak-Król, A; Zalewski, D | 1 |
| Bongarzone, ER; Cologna, SM; Crocker, SJ; Domowicz, MS; Givogri, MI; Heller, GJ; Issa, Y; Marshall, JN; Marshall, MS; Nguyen, D; Pathmasiri, KC; Rue, E; Sands, MS; Tai, LM; van Breemen, RB | 1 |
| Ma, A; Pan, X; Yang, S; Yin, R | 1 |
| de Andrés Frutos, CD; Hidalgo de la Cruz, M; Martínez Ginés, ML; Miranda Acuña, J; Ros, AL; Tapia, SP | 1 |
| Borsa, NG; Garg, N; Khankin, EV; McDermott, S; Meyer, NC; Nicholson-Weller, A; Pavlakis, M; Rennke, HG; Smith, RJ; Stillman, IE; Zhang, Y | 1 |
| Aleksic, N; Babic, S; Calija, B; Gajin, P; Ilijevski, N; Maravic-Stojkovic, V; Matic, P; Nenezic, D; Popov, P; Radak, D; Rancic, Z; Tanaskovic, S; Vasic, D; Vucurevic, G | 1 |
| Alvarez-Bollea, MA; Bastos, L; Guglielmone, HA; Jarchum, GD | 1 |
| Kimura, N; Matsumoto, H; Mieno, M; Okamura, H; Yamaguchi, A; Yuri, K | 1 |
| Akassoglou, K; Bongarzone, ER; Crocker, SJ; Givogri, MI; Han, DK; Jellison, ER; Mendiola, AS; Menoret, A; Nicaise, AM; Ryu, JK; Vella, AT; Willis, CM | 1 |
| Brodowski, K; Jaworski, K; Kosior, DA; Krzykwa, A; Opolski, G; Zylińska, E | 1 |
| Bruinse, HW; Franx, A; Koenen, SV; Koster, MP; Peeters, LL; Post Uiterweer, ED; Scholtens, LC; van Rijn, BB; Veerbeek, JH | 1 |
| Alasady, M; Brooks, AG; Dang, J; Lau, DH; Lim, HS; Roberts-Thomson, KC; Sanders, P; Schultz, C; Willoughby, SR; Wong, CX; Worthley, MI; Young, GD | 1 |
| de Vries, EG; Hospers, GA; Mäkelburg, AB; Schröder, CP; van den Brom, RR | 1 |
| Addas-Carvalho, M; Andrade Orsi, F; Castro Ozelo, M; Comenalli Marques, JF; De Paula, EV; Gasparotto Roveri, E; Maria Annichino-Bizzacchi, J; Pereira Colella, M; Stefanello, B | 1 |
| Ajzenberg, N; Caron, C; Dilly, MP; Fischer, Q; Huisse, MG; Kirsch, M; Lepage, L; Nataf, P; Voiriot, G | 1 |
| Işik, B; Karakukcu, M; Mutlu, FT; Ozdemir, MA; Patiroglu, T; Unal, E; Yilmaz, E | 1 |
| Evtushenko, DA | 1 |
| Ding, YC; Fu, P; Huang, Y; Ji, XM; Ma, X; Xue, Q | 1 |
| Ingebrigtsen, TS; Lange, P; Marott, JL; Nordestgaard, BG; Rode, L; Vestbo, J | 1 |
| Chen, WM; Coull, B; Dupuis, J; Dzhivhuho, G; Furie, KL; Gogarten, SM; Hsu, FC; Keene, KL; Lin, H; Madden, EB; Malik, R; Mehndiratta, P; Nelson, S; Rich, SS; Rowles, JL; Sale, MM; Seshadri, S; Southerland, AM; Williams, SR; Worrall, BB | 1 |
| Berens, C; Hertfelder, HJ; Ivaškevičius, V; Oldenburg, J; Pötzsch, B; Rühl, H | 1 |
| Kamiński, G; Szamotulska, K; Witek, J; Witek, P; Zieliński, G | 1 |
| Amir, AZ; Avitzur, Y; Cattral, M; Cutz, E; De Angelis, M; Fecteau, A; Ghanekar, A; Grant, D; Jones, N; Kamath, B; Ling, SC; Nalli, N; Naqvi, A; Ng, V; Weitzman, S | 1 |
| Declerck, PJ; Gils, A; Jern, C; Jood, K; Lundberg, L; Nilsson, S; Pedersen, A; Redfors, P | 1 |
| Campbell, DJ; Chalmers, J; Lowe, GD; MacMahon, SW; Neal, BC; Rumley, A; Welsh, P; Woodward, M | 1 |
| Applegate, RJ; Ketch, TR; Kutcher, MA; Lingle, KC; Sacrinty, MT; Sane, DC; Turner, SJ | 1 |
| Eskin, T; Kitchens, C | 1 |
| Arentz, T; Bürkle, G; Kalusche, D; Letsas, KP; Mihas, CC; Minners, J; Weber, R | 1 |
| Carvalho, Mda G; Carvalho, PC; da Fonseca, CO; Domont, GB; Fischer, Jde S; Neves-Ferreira, AG; Perales, J | 1 |
| Bian, C; Shi, Y; Wu, Y; Xu, G; Yang, J; Zhang, W | 1 |
| Noris, M; Remuzzi, G | 1 |
| Domagała, TB; Januszek, R; Karkowski, G; Kotula-Horowitz, K; Lelakowski, J; Musiał, J; Piekarz, J; Rydlewska, A | 1 |
| I Kirschner, R; Martin, N; Seifert, SA | 1 |
| Balwierz, W; Iwaniec, T; Neerman-Arbez, M; Pietrys, D; Undas, A; Vorjohann, S | 1 |
| Kontorinis, G; Schwab, B | 1 |
| Altarac, S; Arslani, N; Filipović-Zore, I; Gajzer, B; Papeš, D; Rajković, Z; Zore, Z | 1 |
| de Maat, MP; Deckers, JW; Leebeek, FW; van Domburg, RT; van Loon, JE | 1 |
| Gibbs, SD; Gilbertson, JA; Gillmore, JD; Hawkins, PN; Lachmann, HJ; Pinney, JH; Rowczenio, D; Sattianayagam, PT; Venner, CP; Wechalekar, AD; Whelan, CJ | 1 |
| Bridoux, F; Cassuto, E; Chatelet, V; Delahousse, M; Frémeaux-Bacchi, V; Jablonski, M; Kamar, N; Le Quintrec, M; Lionet, A; Loirat, C; Moulin, B; Mourad, G; Mousson, C; Rondeau, E; Zuber, J | 1 |
| Borrás Pallé, S; Campos Ferrer, C; Gómez Martínez, E; Molina, E; Romero Rodrigo, A; Valentín Segura, V | 1 |
| Balmer, H; Baumgartner, I; Do, DD; Mahler, F; Triller, J | 1 |
| Smith, TP | 1 |
| Alt, E; Banyai, M; Banyai, S; Koppensteiner, R | 1 |
| Breddin, HK; Kadziola, Z; Kakkar, VV; Misselwitz, F; Nakov, R; Scully, M | 1 |
| Bouter, KP; de Jongh, BM; Diepersloot, RJ; Kelder, JC; Plokker, TH; Rahel, BM; Suttorp, MJ; Visseren, FL | 1 |
| Byrne, CE; Cannon, CP; Fitzgerald, A; Fitzgerald, DJ; Shields, DC | 1 |
| Funai, EF; Hart, D; Kim, E; Lee, MJ; Popiolek, D; Roqué, H; Stephenson, C | 1 |
| Bang, NU; Bruno, A; Cohen, SN; Gorelick, PB; McConnell, JP; Richardson, D; Tietjen, GE | 1 |
| Bas, M; Bier, H; Hoffmann, TK; Kojda, G | 1 |
| Acsády, G; Dósa, E; Entz, L; Füst, G; Karádi, I; Prohászka, Z; Romics, L; Rugonfalvi-Kiss, S; Selmeci, L; Szabó, A | 1 |
| Anvari, A; Falkensammer, C; Gyöngyösi, M; Huber, K; Jordanova, N; Khorsand, A; Wojta, J; Zorn, G | 1 |
| Bertomeu, V; Bodí, V; Chorro, FJ; Fácila, L; Llàcer, A; Núñez, J; Pellicer, M; Ruiz, V; Sanchis, J | 1 |
| Abrignani, MG; Braschi, A; Braschi, G; Coppola, G; Corrado, E; Di Girolamo, A; Novo, S; Rizzo, M | 1 |
| Chambless, LE; Folsom, AR; Nieto, FJ; Wattanakit, K | 1 |
| Goudevenos, JA; Kolettis, TM; Korantzopoulos, P; Kountouris, E; Siogas, K | 1 |
| Campbell, DJ; Chalmers, J; Colman, S; Jenkins, AJ; Kemp, BE; Lowe, GD; MacMahon, SW; Neal, BC; Patel, A; Rumley, A; Woodward, M | 1 |
| Brueck, M; Kramer, W; Rauber, K; Runde, T | 1 |
| Alzate, C; Arrieta, AB; Arroyo, Y; Ayala, S; Barona, J; Conrado, LL; Córdoba, E; Díaz, A; Fabra, PE; Fernández, D; Fernández, J; Gutiérrez, JM; León, G; López, M; Meza, JJ; Mosquera, D; Núñez, V; Ospina, CE; Otero, R; Paniagua, CA; Quintana, JC; Ramírez, E; Ramírez, P; Rodríguez, V; Rojas, G; Silva, JF; Theakston, RD; Toro, MF; Warrell, DA | 1 |
| Ayash, LJ; Braun, T; Ratanatharathorn, V; Reynolds, CM; Silver, SM; Uberti, JP | 1 |
| Faught, C; Kolajova, M; Rock, G; Zimmerman, D | 1 |
| Aun, R; Benabou, JE; Casella, IB; Presti, C; Puech-Leão, P | 1 |
| Brant-Zawadzki, PB; Fenton, SJ; Matlak, ME; Nichol, PF; Scaife, ER | 1 |
| Baykara, M; Celik, O; Erdogru, T; Sanli, A | 1 |
| Bagoly, E; Dóczi, T; Fehér, G; Hantó, K; Koltai, K; Komoly, S; Kövér, F; Pozsgai, E; Szapáry, L; Tóth, K | 1 |
| Doggen, CJ; Rosendaal, FR; van der Bom, JG; van der Krabben, MD | 1 |
| Balz, V; Bas, M; Bier, H; Hafner, D; Hochfeld, J; Hoffmann, TK; Kirchhartz, N; Kojda, G; Kumpf, S; Oppermann, M; Suvorava, T; Tüllmann, C | 1 |
| Bellucci, S; Caen, J; Drouet, L; Dupuy, E; Pellerin, A; Soria, C; Tobelem, G | 1 |
| Ballard, JO; Eyster, ME; Kelly, GA; Kukrika, MD; Sanders, JC | 1 |
| Martin, C; Martin, H | 1 |
| Reuss, GU | 1 |
| Hirsh, J; Hull, RD; Jay, RM; LeClerc, JR; Raskob, GE | 1 |
| Reidemeister, JC; Rohm, N; Zerkowski, HR | 1 |
| Benesch, J; Siebenmann, R; Spiegel, M | 1 |
| Barrett, DJ; Boyle, MD | 1 |
| Hull, R | 1 |
| Budzynski, AZ; Ness, PM; Olexa, SA; Rodvien, R | 1 |
| Baughman, DJ; Kostis, JB; Kuo, PT | 1 |
| Löfmark, R | 1 |
| Kopelovich, IuKh | 1 |
| Agnelli, G; Callegari, P; Hauert, J; Iorio, A; Parise, P | 1 |
| Lichtlen, PR; Wolf, R | 1 |
| Eber, B; Esterbauer, H; Gasser, R; Kaufmann, P; Klein, W; Luha, O; Schumacher, M; Tatzber, F | 1 |
| Ankri, A; Drobinski, G; Grosgogeat, Y; Montalescot, G; Thomas, D; Vicaut, E | 1 |
| Meade, TW | 1 |
| Boldt, J; Hempelmann, G; Menges, T; Ruwoldt, R; von Lessen, A; Wagner, RM; Welters, I | 1 |
| Fujisawa, H; Ito, H; Kashiwagi, S; Nakamura, K; Nomura, S | 1 |
| Chiba, K; Sasaki, K; Suzuki, H; Takahashi, H; Tamura, K; Tohgi, H | 1 |
| Cimminiello, C | 1 |
| Geiss-Holtorff, R; Hafner, G; Prellwitz, W | 1 |
| Beamer, N; Coull, BM; de Garmo, P; Knox, R; Seaman, G; Sexton, G | 1 |
| Blombäck, M; Bremme, K; Lind, H | 1 |
| Bielenda, CC; Drews, FR; Fava, M; Halperin, P; Lamon-Fava, S; Littman, AB; MacLaughlin, RA; Oleshansky, MA | 1 |
| Jounela, A; Peuhkurinen, K; Risteli, J; Risteli, L | 1 |
| Cichocka, E; Ksiazek, J; Lukasiewicz, H; Teklińska, E; Wyszyńska, T | 1 |
| Belanger, AJ; D'Agostino, RB; Kannel, WB; Sibershatz, H; Tofler, GT | 1 |
| Heikkilä, J; Kotamäki, M; Laustiola, K; Syvänne, M | 1 |
| Colman, T; García-Fuentes, M; García-Ribes, M; González-Lamuño, D; Revuelta, JM | 1 |
| Aul, C; Bauser, U; Boogen, C; Frieling, T; Germing, U; Heyll, A; Kobbe, G; Schneider, P; Söhngen, D | 1 |
| Grabensee, B; Gradaus, F; Heering, P; Ivens, K; Jax, TW; Leschke, M; Schoebel, FC; Strauer, BE | 1 |
| Jäger, K; Labs, KH; Marbet, GA; Tsakiris, DA; Tschopl, M | 1 |
| Fowkes, FG; Lowe, GD; Mamode, N; Price, JF; Rumley, A; Smith, FB; Woodburn, KR | 1 |
| Bovill, EG; Brown, RG; Cannon, CP; Collen, D; Kleiman, NS; Mahan, E; Mann, KG; Rogers, WJ; Sopko, G; Stump, DC; Thompson, B; Tracy, RP; Williams, DO; Zaret, BL | 1 |
| Fitzpatrick, LA; Holmes, DR; Mousa, SA; Reilly, TM; Schwartz, RS; Srivatsa, SS; Tsao, PW | 1 |
| Beamer, NB; Briley, DP; Clark, WM; Coull, BM; Sexton, G; Wynn, M | 1 |
| Biasucci, LM; Buffon, A; Caligiuri, G; Fadda, G; Ginnetti, F; Grillo, RL; Liuzzo, G; Maseri, A; Rebuzzi, AG; Summaria, F | 1 |
| Boyer, LV; Clark, RF; Dart, RC; McNally, JT; Nordt, SP; Seifert, SA; Walter, FG; Williams, SR | 1 |
| Arora, R; Bodenheimer, MM; Brown, MW; Case, RB; Dwyer, EM; Gillespie, JA; Goldstein, RE; Greenberg, H; Hochman, J; Krone, RJ; Liang, CS; Lichstein, E; Little, WC; Marcus, FI; Marder, VJ; Moss, AJ; Oakes, D; Sparks, CE; Van Voorhees, L; Watelet, LF; Weiss, HJ; Zareba, W | 1 |
| Maksimenko, AV; Tischenko, EG | 1 |
| Greenbaum, AB; Harrington, RA; Hudson, MP; Ohman, EM | 1 |
| Borries, M; Fischer, Y; Heins, M; Leschke, M; Peters, A; Reinauer, H; Schoebel, FC; Stiegler, H; Strauer, BE | 1 |
| Bode, C; Kohler, B; Kübler, W; Peter, K; Schwarz, M; Straub, A; Volkmann, M | 1 |
| Berent, H; Chodakowska, J; Januszewicz, A; Januszewicz, M; Januszewicz, W; Kuczynska, K; Malek, G; Rowinski, O; Symonides, B; Szmigielski, C | 1 |
| Haaxma, R; Henselmans, JM; Hew, J; Meijer, K; van der Meer, J | 1 |
| Biasucci, LM; Buffon, A; Crea, F; Liuzzo, G; Maseri, A; Pasqualetti, P; Ramazzotti, V; Rebuzzi, AG | 1 |
| Aznar, J; Fayos, L; Ferrando, F; Martínez-Sales, V; Reganon, E; Ruano, M; Vila, V | 1 |
| Cannon, CP; Holmes, MB; Schneider, DJ; Sobel, BE | 1 |
| Barlage, S; Lackner, KJ; Schmitz, G; von Landenberg, C | 1 |
| Gabazza, EC; Kageyama, S; Kato, H; Kumeda, K; Masuya, M; Mori, Y; Nakasaki, T; Nishikawa, M; Okugawa, Y; Shiku, H; Wada, H; Watanabe, R | 1 |
| Finke, D; Makosiej, R; Owczarek, D; Ptaśnik, W; Puczko-Nogal, B; Rogowska-Kalisz, A; Tkaczyk, M | 1 |
| Adamus, J; Gil, M; Olszewski, R; Zarebiński, M | 1 |
| Biesenbach, G; Brücke, P; Gross, C; Hubmann, R; Janko, O | 1 |
| Bocola, V; Di Napoli, M; Papa, F | 1 |
| Campeau, L; Forman, S; Fox, NL; Herd, JA; Hickey, A; Hoogwerf, BJ; Hoppensteadt, D; Hunninghake, DB; Pifarré, R; Probstfield, JL; Terrin, ML; Walenga, JM | 1 |
| Chew, DP; Moliterno, DJ; Mukherjee, D; Raymond, RE; Robbins, M; Yadav, JS | 1 |
| Bogaty, P; Boyer, L; Dagenais, GR; Poirier, P; Simard, S; Solymoss, S | 1 |
| Ahmadi, R; Exner, M; Haumer, M; Minar, E; Mlekusch, W; Schillinger, M; Schlerka, G | 1 |
| Aznar, J; Martinez, M; Martínez-Sales, V; Palencia, MA; Réganon, E; Vayá, A; Vila, V | 1 |
| Barmeyer, J; Bojara, W; Germing, A; Grewe, P; Lawo, T; Lemke, B; Machraoui, A; von Dryander, S | 1 |
| Benetou, V; Bots, ML; Elwood, PC; Freire de Concalves, A; Grobbee, DE; Inzitari, D; Koudstaal, PJ; Moons, KG; Nikitin, Y; Salonen, JT; Sivenius, J; Tuomilehto, J | 1 |
| Coccheri, S; Legnani, C; Lunghi, B; Palareti, G; Preda, L; Rossi, E | 1 |
| Alekseeva, IA; Dobrovol'skiĭ, AB; Liakishev, AA; Nasonov, EL; Naumov, VG; Parfenova, EV; Tkachuk, VA | 1 |
| Di Napoli, M; Papa, F | 1 |
| Aken, WG; Gallus, AS; Hirsh, J; Hull, R | 1 |
| Yoshida, Y | 1 |
| Ellis, J; Genton, E; Steele, P | 1 |
| Panis, R; Rettinger, G | 1 |
| Dawson, AA; Dhall, DP; Mavor, GE | 2 |
| Bliss, BP; Harris, PL; Harvey, DR | 1 |
| Hirsh, J; Kaplan, KL; Nossel, HL; Yudelman, IM | 1 |
| Bulin, VA; Iliushina, IP; Mazur, NA; Metalitsa, VI; Zhukov, VN | 1 |
| Schramm, W; Stefani, FH | 1 |
| Malyĭ, VP | 1 |
| Barnes, RW; Hoak, JC; Wu, KK | 2 |
| Burr, ML; Fehily, AM; Holliday, RM; Whitehead, PJ | 1 |
| Aiach, M; Capron, L; Costa, JM; Fiessinger, JN | 1 |
| Pekkanen, J; Rasi, V; Salomaa, V | 1 |
| Barrett, JS; Cuca, GC; Gardell, SJ; Holahan, MA; Li, P; Lynch, JJ; Mellott, MJ; Stabilito, II; Wang, S | 1 |
| Bär, F; Meyer, J; Ostermann, H; Schmitz-Huebner, U; van de Loo, J; Windeler, J | 1 |
| Eber, B; Gasser, R; Klein, W; Luha, O; Schumacher, M; Tiran, A; Toplak, H | 1 |
| Arnout, J; Collen, D; de Bono, D; Rapold, HJ; Simoons, M; Verstraete, M | 1 |
| Califf, RM; Ellis, SG; George, BS; Kereiakes, DJ; Samaha, JK; Sigmon, K; Topol, EJ; Wall, TC; Worley, SJ | 1 |
| Andreotti, F; Brunelli, C; Buller, N; Caponnetto, S; Foale, R; Fussell, A; Hackett, D; Haider, AW; Lipkin, D; Shahi, M | 1 |
| Greenhalgh, RM; Powell, JT | 1 |
| Eaglstein, WH; Falanga, V; Katz, MH; Kerdel, FA; Kirsner, RS | 1 |
| Bath, PM; Burr, ML; Martin, JF | 1 |
| Eschenfelder, V; Rübsamen, K | 1 |
| Attubato, MJ; Drew, TM; Feit, F; McDonald, MJ; McKendall, GR; Sharaf, BL; Teichman, S; Thomas, ES; Williams, DO | 1 |
| Kerdel, FA; Klein, AD | 1 |
| Aghai, E; Falber, V; Froom, P; Quitt, M; Sova, J; Veisler, A | 1 |
| Hamsten, A; Wiman, B | 1 |
| Barbarotto, R; D'Angelo, A; Landi, G; Mannuccio Mannucci, P; Morabito, A | 1 |
| Douglas, JT; George, WD; Lowe, GD; McCulloch, P; Murray, GD | 1 |
| Artru, F; Convert, J; Deschamps, J; Jourdan, C; Lamy, B; Leclerc, R; Tixier, S | 1 |
| Aznar, J; Lacueva, V; Laiz, B; Regañón, E; Ruano, M; Vila, V | 1 |
| Runge, MS | 1 |
| Hagert, M; Metzner, H; Rode, B | 1 |
| Christiansen, L; Schultz, A; Thorup, J | 1 |
| Brauneis, J; Laskawi, R; Shröder, J | 1 |
| Kaiser, D | 1 |
| Barthels, M; Daniel, WG; Fischer, K; Gulba, DC; Lichtlen, PR; Polensky, U; Reil, GH; Welzel, D | 1 |
| Sonoki, H; Sugimoto, T; Tomaru, T; Tsukamoto, M; Uchida, Y | 1 |
| Baur, H; Haeberli, A; Kuemmerli, H; Rapold, HJ; Weiss, M | 1 |
| Bennett, KA; Booth, DC; Branco, MC; DeMaria, AN; Grines, CL; Gurley, JC; Nissen, SE | 1 |
| Feuerer, W; Jeep-Tebbe, S; Neuhaus, KL; Niederer, W; Tebbe, U; Vogt, A | 1 |
| Andersen, E; Bülow, J; Holstein, P; Jørgensen, B; Jørgensen, M; Nielsen, JD; Tønnesen, KH | 1 |
| Elias, A; Serradimigni, A | 1 |
| Akamine, K; Irabu, Y; Kakazu, T; Kaneshima, H; Kitsukawa, K; Kuniyoshi, T; Miyagi, M; Nakamura, H; Shigeno, Y; Shimoji, K | 1 |
| Blombäck, M; Dahlén, G; de Faire, U; Hamsten, A; Landou, C; Szamosi, A; Walldius, G; Wiman, B | 1 |
| Bonnet, JL; Bory, M; Bouvier, JL; Camilleri, JF; Djiane, P; Levy, G; Serradimigni, A | 1 |
| Sonoki, H; Sugimoto, T; Tomaru, T; Uchida, Y | 1 |
| Bollinger, A; Brülisauer, M; Brüngger, A; Mitsuhashi, Y; Schneider, BV; Schnyder, UW | 1 |
| Been, M; Boulton, FE; de Bono, DP; Fears, R; Ferres, H; Muir, AL; Standring, R | 1 |
| Mittelbach, F; Stüttgen, G | 1 |
| Bonnet, JL; Sainsous, J; Serradimigni, A | 1 |
| Eide, E; Jurgeit, H | 1 |
| Kelâmi, A; Papadopoulos, I; Schnapka, B | 1 |
| Gschrey, G; Haid, T | 1 |
| Krebber, HJ; Mathey, D; Rodewald, G | 1 |
| Petrović, V; Stajcić, Z; Todorović, LJ | 1 |
| Gangadharan, V; Gordon, S; Hauser, AM; Mammen, EF; Ramos, RG; Stewart, JR; Timmis, GC; Westveer, DC | 1 |
| Greenfield, LJ; Hoffman, MJ; Langham, MR | 1 |
| Branson, HE; Brown, DR; Capdeville, MJ; Elias, AN; Lehmer, RR | 1 |
| Chakrabarti, R; Fearnley, GR | 1 |
| Bielawiec, M; Myśliwiec, M; Perzanowski, A | 1 |
| Flute, PT; Lewis, ML; Rake, MO; Shilkin, KB; Williams, R; Winch, J | 1 |
| Judkiewicz, L; Pawlowski, J | 1 |
| Berger, H | 1 |
| Bürgi, H | 1 |
| Patel, VJ | 1 |
| Gervin, AS; Puckett, CL; Silver, D | 1 |
| Allardyce, M; Dawson, AA; Dhall, DP; Duthie, JS; Mahaffy, RG; Mavor, GE; Walker, MG | 1 |
| Tovi, D | 1 |
| Conard, J; Samama, M | 1 |
| Isacson, S; Nilsson, IM | 1 |
| Bradley, J; Brearley, R; Cuschieri, A; Moossa, AR | 1 |
| Nitzschner, HH | 1 |
11 review(s) available for fibrinogen and Recrudescence
| Article | Year |
|---|---|
Biomarkers of cerebral microembolic signals.
Topics: Biomarkers; Brain Ischemia; Chemokine CXCL16; Fibrinogen; Fibrinolytic Agents; Humans; Intracranial Embolism; Neutrophils; Osteoprotegerin; P-Selectin; Plaque, Atherosclerotic; Prognosis; Recurrence; Stroke; T-Lymphocytes, Regulatory | 2017 |
Vemurafenib-Induced Disseminated Intravascular Coagulation in Metastatic Melanoma.
Topics: Acute Disease; Antineoplastic Agents; Biomarkers; Biomarkers, Tumor; Brain Neoplasms; Databases, Factual; Disseminated Intravascular Coagulation; Drug Administration Schedule; Fatal Outcome; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Indoles; L-Lactate Dehydrogenase; Male; Melanoma; Middle Aged; Mutation; Pharmacovigilance; Platelet Count; Proto-Oncogene Proteins B-raf; Recurrence; S100 Calcium Binding Protein beta Subunit; Skin Neoplasms; Sulfonamides; Tumor Burden; Vemurafenib | 2015 |
[Molecular abnormalities in recurrent thromboembolic disease].
Topics: Antithrombin III Deficiency; C-Reactive Protein; Fibrinogen; Fibrinolysis; Humans; Recurrence; Thromboembolism | 1983 |
The diagnosis of clinically suspected venous thrombosis.
Topics: Cost-Benefit Analysis; Diagnosis, Differential; Fibrinogen; Humans; Iodine Radioisotopes; Phlebography; Plethysmography, Impedance; Radionuclide Imaging; Recurrence; Thrombophlebitis; Ultrasonography | 1984 |
Fibrinogen in ischaemic heart disease.
Topics: Blood Viscosity; Cholesterol; Coronary Artery Disease; Coronary Disease; Coronary Thrombosis; Fibrinogen; Humans; Myocardial Infarction; Platelet Aggregation; Prospective Studies; Recurrence; Risk Factors | 1995 |
New thrombolytic strategy: bolus administration of tPA and urokinase-fibrinogen conjugate.
Topics: Animals; Dogs; Drug Combinations; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hemorrhage; Humans; Myocardial Infarction; Recurrence; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 1999 |
Use of glycoprotein IIb/IIIa inhibition plus fibrinolysis in acute myocardial infarction.
Topics: Abciximab; Acetates; Animals; Antibodies, Monoclonal; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Dogs; Double-Blind Method; Drug Evaluation, Preclinical; Drug Therapy, Combination; Eptifibatide; Fibrinogen; Fibrinolytic Agents; Forecasting; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Pilot Projects; Plasminogen Activators; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome; Tyrosine | 1999 |
Diagnosis of venous thromboembolism.
Topics: Doppler Effect; Fibrinogen; Humans; Iodine Radioisotopes; Leg; Lung; Phlebography; Plethysmography; Pulmonary Artery; Pulmonary Embolism; Radiography, Thoracic; Radionuclide Imaging; Recurrence; Rheology; Thrombophlebitis; Ultrasonics; Veins | 1976 |
[Coagulation factors, platelets and coronary heart disease].
Topics: Blood Coagulation Factors; Coronary Disease; Factor VII; Female; Fibrinogen; Humans; Male; Myocardial Infarction; Platelet Aggregation; Recurrence; Tissue Plasminogen Activator | 1991 |
Non-coronary thrombolysis.
Topics: Arterial Occlusive Diseases; Combined Modality Therapy; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Intracranial Embolism and Thrombosis; Recurrence; Thrombin Time; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator | 1990 |
[Principles of thrombolytic treatment].
Topics: Embolism; Fibrinogen; Fibrinolysin; Heparin; Humans; Injections, Intravenous; Peptide Hydrolases; Plasminogen; Recurrence; Streptokinase; Thromboembolism; Thrombosis | 1972 |
24 trial(s) available for fibrinogen and Recrudescence
| Article | Year |
|---|---|
Risk factors and coagulation parameters in relationship to phlebographic response and clinical outcome in the treatment of acute deep vein thrombosis.
Topics: Acute Disease; Adult; Aged; Anticoagulants; Antithrombin III; Biomarkers; Drug Administration Schedule; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Heparin, Low-Molecular-Weight; Humans; Injections, Intravenous; Injections, Subcutaneous; Male; Middle Aged; Peptide Fragments; Peptide Hydrolases; Phlebography; Prothrombin; Recurrence; Risk Factors; Severity of Illness Index; Thrombophlebitis; Treatment Outcome | 2003 |
Associations of inflammatory and hemostatic variables with the risk of recurrent stroke.
Topics: Aged; Brain Ischemia; C-Reactive Protein; Case-Control Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Inflammation; Intracranial Hemorrhages; Ischemic Attack, Transient; Male; Middle Aged; Odds Ratio; Perindopril; Placebos; Recurrence; Risk; Risk Factors; Stroke | 2005 |
Reassessment of defibrase in treatment of acute cerebral infarction: a multicenter, randomized, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Batroxobin; Cerebral Hemorrhage; Cerebral Infarction; Double-Blind Method; Drug Administration Schedule; Female; Fibrinogen; Fibrinolytic Agents; Humans; Male; Middle Aged; Quality Control; Recurrence | 2005 |
Efficacy and safety of two whole IgG polyvalent antivenoms, refined by caprylic acid fractionation with or without beta-propiolactone, in the treatment of Bothrops asper bites in Colombia.
Topics: Adolescent; Adult; Aged; Animals; Antivenins; Blood Coagulation Disorders; Bothrops; Caprylates; Chemical Fractionation; Child; Child, Preschool; Crotalid Venoms; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Immunoglobulin G; Male; Mice; Middle Aged; Propiolactone; Recurrence; Snake Bites; Treatment Outcome; Whole Blood Coagulation Time | 2006 |
Unrelated donor bone marrow transplantation using a chemotherapy-only preparative regimen for adults with high-risk acute myelogenous leukemia.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chronic Disease; Disease-Free Survival; Doxorubicin; Factor XIII; Female; Fibrinogen; Follow-Up Studies; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; Remission Induction; Retrospective Studies; Thrombin; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous | 2007 |
Comparison of symptomatic and asymptomatic reinfarctions after small subcortical stroke.
Topics: Aged; Aspirin; Cerebral Angiography; Cerebral Infarction; Cholesterol, HDL; Female; Fibrinogen; Follow-Up Studies; Hematocrit; Humans; Intracranial Arteriosclerosis; Lipoprotein(a); Male; Middle Aged; Neurologic Examination; Recurrence; Risk Factors; Ticlopidine; Tomography, X-Ray Computed | 1994 |
Changes in interstitial collagen metabolism during acute myocardial infarction treated with streptokinase or tissue plasminogen activator.
Topics: Antithrombins; Collagen; Coronary Thrombosis; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Follow-Up Studies; Heart Rupture, Post-Infarction; Humans; Male; Middle Aged; Myocardial Infarction; Peptide Fragments; Plasminogen Activators; Procollagen; Recurrence; Streptokinase; Tissue Plasminogen Activator | 1996 |
[Molecular markers of hemostasis activation in children with nephrotic syndrome].
Topics: Biomarkers; Blood Coagulation; Child; Child, Preschool; Dicumarol; Female; Fibrinogen; Humans; Male; Nephrotic Syndrome; Platelet Count; Recurrence; Thrombosis | 1995 |
Relation of coagulation parameters to patency and recurrent ischemia in the Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial.
Topics: Fibrinogen; Humans; Myocardial Infarction; Partial Thromboplastin Time; Plasminogen; Recurrence; Thrombolytic Therapy; Tissue Plasminogen Activator; Vascular Patency | 1998 |
A double-blind randomised dose-effect trial of anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction. The APSAC Research Group.
Topics: Anistreplase; Blood Pressure; Coronary Angiography; Coronary Circulation; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fibrinogen; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Recurrence; Safety; Thrombolytic Therapy; Treatment Outcome; Vascular Patency | 1993 |
Increased platelet reactivity in patients given orbofiban after an acute coronary syndrome: an OPUS-TIMI 16 substudy. Orbofiban in Patients with Unstable coronary syndromes. Thrombolysis In Myocardial Infarction.
Topics: Acute Disease; Administration, Oral; Alanine; Blood Platelets; Coronary Thrombosis; Fibrinogen; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Recurrence; Thrombolytic Therapy; Treatment Outcome | 2000 |
[Fibrinogen serum levels in patients with stable coronary artery disease and acute coronary syndrome].
Topics: Aged; Angina, Unstable; Chi-Square Distribution; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Recurrence | 2000 |
Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke.
Topics: Aged; Brain Ischemia; C-Reactive Protein; Female; Fibrinogen; Follow-Up Studies; Humans; Logistic Models; Male; Multivariate Analysis; Predictive Value of Tests; Prognosis; Recurrence; Risk Factors; Severity of Illness Index; Stroke; Survival Analysis; Survival Rate | 2001 |
The hemostatic effects of warfarin titration in post CABG patients in comparison to placebo treatment.
Topics: Adult; Aged; Anticoagulants; Aspirin; Coronary Artery Bypass; Coronary Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Factor VII; Female; Fibrinogen; Graft Occlusion, Vascular; Humans; International Normalized Ratio; Male; Middle Aged; Peptide Fragments; Postoperative Complications; Postoperative Hemorrhage; Prothrombin; Recurrence; Saphenous Vein; Thrombosis; Tissue Plasminogen Activator; Treatment Outcome; von Willebrand Factor; Warfarin | 2001 |
Effects of platelet suppressant, anticoagulant and fibrinolytic therapy in patients with recurrent venous thrombosis.
Topics: Adult; Aged; Anticoagulants; Blood Platelets; Cell Survival; Clinical Trials as Topic; Ethylestrenol; Female; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Heparin; Humans; Male; Middle Aged; Phenformin; Placebos; Recurrence; Sulfinpyrazone; Thrombophlebitis; Warfarin | 1978 |
Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART).
Topics: Blood Viscosity; Dietary Fats; Dietary Fiber; Fibrinogen; Fish Oils; Follow-Up Studies; Hemoglobinometry; Humans; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Platelet Count; Recurrence; Smoking; Smoking Cessation; Survival Rate | 1992 |
Rate of fibrinogen breakdown related to coronary patency and bleeding complications in patients with thrombolysis in acute myocardial infarction--results from the PRIMI trial.
Topics: Blood Coagulation Tests; Coronary Circulation; Coronary Thrombosis; Double-Blind Method; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Hemostasis; Humans; Myocardial Infarction; Recombinant Proteins; Recurrence; Streptokinase; Thrombolytic Therapy; Urokinase-Type Plasminogen Activator; Vascular Patency | 1992 |
Correlation between level of heparinization and patency of the infarct-related coronary artery after treatment of acute myocardial infarction with alteplase (rt-PA).
Topics: Adult; Aged; Blood Coagulation; Coronary Vessels; Drug Therapy, Combination; Female; Fibrinogen; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Recurrence; Thrombolytic Therapy; Tissue Plasminogen Activator; Vascular Patency | 1992 |
Accelerated plasminogen activator dose regimens for coronary thrombolysis. The TAMI-7 Study Group.
Topics: Adult; Aged; Drug Therapy, Combination; Female; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Recombinant Proteins; Recurrence; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Urokinase-Type Plasminogen Activator; Vascular Patency; Ventricular Function, Left | 1992 |
Influence of platelet size on outcome after myocardial infarction.
Topics: Aged; Blood Viscosity; Blood Volume; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Humans; Leukocyte Count; Male; Megakaryocytes; Myocardial Infarction; Platelet Count; Prognosis; Recurrence; Risk Factors; Time Factors | 1991 |
Safety and efficacy of a new regimen of intravenous recombinant tissue-type plasminogen activator potentially suitable for either prehospital or in-hospital administration.
Topics: Adult; Clinical Protocols; Coronary Angiography; Emergency Medical Services; Female; Fibrinogen; Hemorrhage; Hospitalization; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; New York City; Recurrence; Rhode Island; Tissue Plasminogen Activator; Vascular Patency | 1991 |
Intravenous streptokinase versus heparin in the acute stage of myocardial infarction. A prospective randomised trial in south-east France.
Topics: Adult; Coronary Angiography; Creatine Kinase; Electrocardiography; Female; Fibrinogen; Heparin; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Random Allocation; Recurrence; Streptokinase | 1986 |
[Value in pulmonary diseases of a new broad spectrum semi-synthetic penicillin: amoxicillin].
Topics: Amines; Ampicillin; Bacteria; Bacterial Infections; Bronchi; Bronchitis; Cephalosporins; Chloramphenicol; Chronic Disease; Clinical Trials as Topic; DNA; Fibrinogen; Humans; L-Lactate Dehydrogenase; Leukocyte Count; Mucus; Penicillins; Recurrence; Respiratory Tract Infections; Saliva; Tetracycline | 1973 |
[Coagulum-pyelolithotomy (author's transl)].
Topics: Adult; Clinical Trials as Topic; Fibrinogen; Humans; Kidney Calculi; Kidney Pelvis; Male; Methods; Postoperative Complications; Radiography; Recurrence; Thrombin; Ureteral Calculi | 1974 |
182 other study(ies) available for fibrinogen and Recrudescence
| Article | Year |
|---|---|
Overexpression of miR-17 predicts adverse prognosis and disease recurrence for acute myeloid leukemia.
Topics: Fibrinogen; Gene Expression Regulation, Leukemic; Humans; Leukemia, Myeloid, Acute; MicroRNAs; Prognosis; Recurrence | 2022 |
Transversalis fascia suture reinforcement may facilitate the performance of electrospun P(LLA-CL) nanoscale fibrinogen mesh in inguinal hernia repair: a prospective single-center cohort study.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Fascia; Fibrinogen; Hemostatics; Hernia, Inguinal; Humans; Male; Middle Aged; Pain, Postoperative; Prospective Studies; Recurrence; Surgical Mesh; Sutures | 2023 |
Congenital hypofibrinogenemia associated with a novel heterozygous nonsense mutation in the globular C-terminal domain of the γ-chain (p.Glu275Stop).
Topics: Afibrinogenemia; Anticoagulants; Blood Coagulation Tests; Codon, Nonsense; Fibrinogen; Genetic Predisposition to Disease; Genetic Testing; Humans; Male; Middle Aged; Recurrence; Thrombelastography; Venous Thrombosis; Warfarin | 2020 |
Macrophage activation syndrome as a complication of rheumatologic disorders, a report from Iran.
Topics: Arthritis, Juvenile; Child; Child, Preschool; Female; Fibrinogen; Humans; Infant; Iran; Lupus Erythematosus, Systemic; Macrophage Activation Syndrome; Male; Mucocutaneous Lymph Node Syndrome; Platelet Count; Prospective Studies; Recurrence; Symptom Assessment | 2020 |
Predictive Factors for Pre-operative Recurrence of Cerebrovascular Symptoms in Symptomatic Carotid Stenosis.
Topics: Aged; Amaurosis Fugax; Carotid Stenosis; Cross-Sectional Studies; Endarterectomy, Carotid; Female; Fibrinogen; Humans; Hypertension; Ischemic Attack, Transient; Kaplan-Meier Estimate; Lipoproteins, HDL; Lipoproteins, LDL; Longitudinal Studies; Male; Middle Aged; Preoperative Period; Proportional Hazards Models; Prospective Studies; Protective Factors; Recurrence; Risk Factors; Stroke; Time Factors | 2020 |
Involvement of hemostasis in pathophysiology of RAO in horses.
Topics: Airway Obstruction; Animals; Blood Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemostasis; Horses; Male; Recurrence | 2020 |
Waning efficacy in a long-term AAV-mediated gene therapy study in the murine model of Krabbe disease.
Topics: Animals; Animals, Newborn; Cells, Cultured; Dependovirus; Disease Models, Animal; Female; Fibrinogen; Galactosylceramidase; Genetic Therapy; Genetic Vectors; Leukodystrophy, Globoid Cell; Male; Mice; Recurrence; White Matter | 2021 |
Elevated plasma fibrinogen levels in multiple sclerosis patients during relapse.
Topics: Adult; Biomarkers; Brain; Female; Fibrinogen; Humans; Magnetic Resonance Imaging; Male; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Recurrence; Sensitivity and Specificity; Spinal Cord | 2017 |
C3 glomerulonephritis secondary to mutations in factors H and I: rapid recurrence in deceased donor kidney transplant effectively treated with eculizumab.
Topics: Allografts; Antibodies, Monoclonal, Humanized; Biomarkers; Biopsy; Complement Activation; Complement Factor H; Complement Pathway, Alternative; DNA; DNA Mutational Analysis; Fibrinogen; Glomerulonephritis; Humans; Kidney Failure, Chronic; Kidney Glomerulus; Kidney Transplantation; Male; Middle Aged; Mutation; Pedigree; Recurrence; Tissue Donors | 2018 |
Scoring system to predict early carotid restenosis after eversion endarterectomy by analysis of inflammatory markers.
Topics: Aged; Algorithms; Aspirin; Biomarkers; C-Reactive Protein; Cardiovascular Agents; Carotid Stenosis; Clinical Decision-Making; Complement C3; Computed Tomography Angiography; Databases, Factual; Decision Support Techniques; Endarterectomy, Carotid; Female; Fibrinogen; Humans; Inflammation Mediators; Male; Middle Aged; Predictive Value of Tests; Recurrence; Retrospective Studies; Risk Assessment; Risk Factors; Sex Factors; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Color | 2018 |
Recurrent superficial venous thrombophlebitis because of mutations in the protein C and fibrinogen genes in a young Argentinian female.
Topics: Afibrinogenemia; Argentina; Female; Fibrinogen; Heterozygote; Humans; Mutation, Missense; Protein C; Recurrence; Sequence Analysis, DNA; Thrombophlebitis; Venous Thrombosis; Young Adult | 2019 |
Sutureless repair for postinfarction left ventricular free wall rupture.
Topics: Aged; Aged, 80 and over; Aprotinin; Databases, Factual; Drug Combinations; Female; Fibrinogen; Heart Rupture, Post-Infarction; Hospital Mortality; Humans; Japan; Male; Middle Aged; Recurrence; Reoperation; Retrospective Studies; Risk Factors; Sutureless Surgical Procedures; Thrombin; Time Factors; Treatment Outcome | 2019 |
Extracellular vesicle fibrinogen induces encephalitogenic CD8+ T cells in a mouse model of multiple sclerosis.
Topics: Animals; CD8-Positive T-Lymphocytes; Encephalomyelitis, Autoimmune, Experimental; Extracellular Vesicles; Fibrinogen; Humans; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Recurrence | 2019 |
[Role of inflammation in etiology of atrial fibrillation--is lone arrhythmia really alone].
Topics: Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Fibrinogen; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Middle Aged; Pyrroles; Recurrence | 2012 |
C-reactive protein and fibrinogen levels as determinants of recurrent preeclampsia: a prospective cohort study.
Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Female; Fibrinogen; Gestational Age; Humans; Infant, Newborn; Inflammation Mediators; Labor, Induced; Pre-Eclampsia; Pregnancy; Pregnancy Trimester, Third; Prospective Studies; Recurrence; Risk Factors | 2014 |
Time course of inflammation, myocardial injury, and prothrombotic response after radiofrequency catheter ablation for atrial fibrillation.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Catheter Ablation; Creatine Kinase, MB Form; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Injuries; Humans; Inflammation; Inflammation Mediators; Male; Middle Aged; Prospective Studies; Recurrence; Risk Factors; Thrombosis; Time Factors; Treatment Outcome; Troponin T | 2014 |
Safety and efficacy of cryoprecipitate-poor plasma as a replacement fluid for therapeutic plasma exchange in thrombotic thrombocytopenic purpura: a single center retrospective evaluation.
Topics: ADAM Proteins; ADAMTS13 Protein; Adult; Chills; Factor VIII; Female; Fever; Fibrinogen; Gastrointestinal Diseases; Humans; Hypersensitivity; Male; Middle Aged; Plasma; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Recurrence; Retrospective Studies; Young Adult | 2014 |
Von Willebrand factor, a versatile player in gastrointestinal bleeding in left ventricular assist device recipients?
Topics: Aged; Combined Modality Therapy; Deamino Arginine Vasopressin; Embolization, Therapeutic; Erythrocyte Transfusion; Fibrinogen; Gastrointestinal Hemorrhage; Heart Ventricles; Heart-Assist Devices; Hemostatics; Humans; Laser Coagulation; Male; Neovascularization, Physiologic; Postoperative Hemorrhage; Recurrence; Tranexamic Acid; von Willebrand Factor | 2015 |
A case of congenital afibrinogenemia complicated with thromboembolic events that required repeated amputations.
Topics: Afibrinogenemia; Amputation, Surgical; Anemia; Anticoagulants; Blood Coagulation Tests; Disease Progression; Enoxaparin; Female; Fibrinogen; Foot; Heparin; Humans; Ischemia; Necrosis; Recurrence; Toes; Young Adult | 2015 |
[Prognostication and prophylaxis of the adhesions recurrence postoperatively in patients suffering acute adhesive peritoneal disease complicated by ileus].
Topics: Acute Disease; Anastomosis, Surgical; Aprotinin; Drug Combinations; Female; Fibrinogen; Glycosaminoglycans; Humans; Hydroxyproline; Ileus; Male; Postoperative Complications; Recurrence; Thrombin; Tissue Adhesions; Uronic Acids | 2015 |
Coexistence of High Fibrinogen and Low High-density Lipoprotein Cholesterol Levels Predicts Recurrent Cerebral Venous Thrombosis.
Topics: Adolescent; Adult; Aged; Cholesterol, HDL; Cohort Studies; Female; Fibrinogen; Humans; Intracranial Thrombosis; Male; Middle Aged; Recurrence; Retrospective Studies; Young Adult | 2015 |
Fibrinogen and α1-antitrypsin in COPD exacerbations.
Topics: Aged; Alleles; alpha 1-Antitrypsin; Female; Fibrinogen; Forced Expiratory Volume; Genetic Testing; Genotype; Humans; Male; Pulmonary Disease, Chronic Obstructive; Recurrence; Retrospective Studies | 2015 |
Shared genetic susceptibility of vascular-related biomarkers with ischemic and recurrent stroke.
Topics: Aged; Biomarkers; Brain Ischemia; C-Reactive Protein; Female; Fibrinogen; Gene Expression; Genetic Loci; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Male; Middle Aged; Oxidoreductases; Polymorphism, Single Nucleotide; Randomized Controlled Trials as Topic; Recurrence; Stroke | 2016 |
Recurrent VTE in a heterozygote of the fibrinogen Aα IVS4+1G>T and Aα p.Arg168Ter mutation.
Topics: Adolescent; Afibrinogenemia; Anticoagulants; Female; Fibrinogen; Fibrinogens, Abnormal; Hemorrhage; Heterozygote; Humans; Mutation; Recurrence; Venous Thromboembolism | 2016 |
Cushing`s disease: Fibrinogen and D-dimer levels fail to normalize despite early postoperative remission - a prospective, controlled study.
Topics: Adolescent; Adult; Aged; Case-Control Studies; Cushing Syndrome; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Postoperative Period; Prospective Studies; Recurrence; Young Adult | 2016 |
Liver transplantation for children with acute liver failure associated with secondary hemophagocytic lymphohistiocytosis.
Topics: Adolescent; Biopsy; Child; Child, Preschool; Cross-Sectional Studies; Disease Progression; Female; Ferritins; Fibrinogen; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infant; Liver; Liver Failure, Acute; Liver Transplantation; Lymphohistiocytosis, Hemophagocytic; Male; Rare Diseases; Recurrence; Retrospective Studies; Survival Rate; Time-to-Treatment; Treatment Outcome; Triglycerides | 2016 |
Haemostatic biomarkers are associated with long-term recurrent vascular events after ischaemic stroke.
Topics: Aged; Biomarkers; Carboxypeptidase B2; Cardiovascular Diseases; Female; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Recurrence; Stroke; Tissue Plasminogen Activator; von Willebrand Factor | 2016 |
Associations of proinflammatory cytokines with the risk of recurrent stroke.
Topics: Acute-Phase Reaction; Aged; Biomarkers; Brain Ischemia; C-Reactive Protein; Case-Control Studies; Cerebral Hemorrhage; Cytokines; Female; Fibrinogen; Humans; Interleukin-18; Interleukin-6; Male; Middle Aged; Multivariate Analysis; Recurrence; Risk Factors; Stroke; Tumor Necrosis Factor-alpha | 2008 |
Derived fibrinogen compared with C-reactive protein and brain natriuretic peptide for predicting events after myocardial infarction and coronary stenting.
Topics: Aged; Angioplasty, Balloon, Coronary; C-Reactive Protein; Coronary Artery Bypass; Female; Fibrinogen; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Prognosis; Proportional Hazards Models; Prothrombin Time; Recurrence; Retrospective Studies; Risk Assessment; Stents | 2008 |
Fatality in a case of envenomation by Crotalus adamanteus initially successfully treated with polyvalent ovine antivenom followed by recurrence of defibrinogenation syndrome.
Topics: Animals; Antivenins; Blood Coagulation; Brain Edema; Cause of Death; Cerebral Hemorrhage; Crotalus; Fatal Outcome; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Platelet Count; Recurrence; Sheep; Snake Bites | 2008 |
Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation.
Topics: Atrial Fibrillation; C-Reactive Protein; Catheter Ablation; Female; Fibrinogen; Follow-Up Studies; Heart Atria; Heart Ventricles; Humans; Hypertension; Inflammation; Leukocyte Count; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Pulmonary Veins; Recurrence; Regression Analysis; Retrospective Studies; Risk Factors; Ventricular Dysfunction, Left | 2009 |
Anti-thrombin as a prognostic biomarker candidate for patients with recurrent glioblastoma multiform under treatment with perillyl alcohol.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Central Nervous System Neoplasms; Disease Progression; Electrophoresis, Polyacrylamide Gel; Fibrin; Fibrinogen; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Mass Spectrometry; Monoterpenes; Proteomics; Recurrence | 2008 |
Predictive value of plasma fibrinogen levels in patients admitted for acute coronary syndrome.
Topics: Acute Coronary Syndrome; Adult; Aged; Biomarkers; C-Reactive Protein; Chi-Square Distribution; Coronary Angiography; Coronary Stenosis; Female; Fibrinogen; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Odds Ratio; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Recurrence; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors | 2010 |
Thrombotic microangiopathy after kidney transplantation.
Topics: Autoantibodies; Blood Component Transfusion; Child; Complement Factor H; Complement Pathway, Alternative; Complement System Proteins; Escherichia coli Infections; Fibrinogen; Hemolytic-Uremic Syndrome; Humans; Kidney Transplantation; Liver Transplantation; Mutation; Plasma; Postoperative Complications; Recurrence; Thrombotic Microangiopathies; Treatment Failure; Treatment Outcome | 2010 |
[Venous thrombosis as a complication of pacemaker implantation--own observations].
Topics: Aged; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Follow-Up Studies; Humans; Interleukin-6; Male; Middle Aged; Pacemaker, Artificial; Plasminogen Activator Inhibitor 1; Prosthesis Implantation; Recurrence; Risk Factors; Smoking; Stroke Volume; Venous Thrombosis | 2011 |
Recurrent, persistent, or late, new-onset hematologic abnormalities in Crotaline snakebite.
Topics: Adolescent; Adult; Aged; Animals; Antivenins; Child; Child, Preschool; Crotalus; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Infant; International Normalized Ratio; Male; Middle Aged; Partial Thromboplastin Time; Platelet Count; Recurrence; Retrospective Studies; Snake Bites | 2011 |
Two different fibrinogen gene mutations associated with bleeding in the same family (A αGly13Glu and γGly16Ser) and their impact on fibrin clot properties: fibrinogen Krakow II and Krakow III.
Topics: Adult; Blood Coagulation Disorders; Child; DNA Mutational Analysis; Fibrinogen; Genetic Association Studies; Hemorrhage; Humans; Male; Middle Aged; Mutation; Pedigree; Poland; Prothrombin Time; Recurrence | 2011 |
Significance of advanced haemostasis investigation in recurrent, severe post-tonsillectomy bleeding.
Topics: Adolescent; Adult; Blood Coagulation Disorders; Blood Coagulation Tests; Child; Female; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Postoperative Care; Postoperative Hemorrhage; Postoperative Period; Predictive Value of Tests; Recurrence; Smoking; Tonsillectomy; Young Adult | 2011 |
A new approach for transversalis fascia reinforcement in Lichtenstein's inguinal hernia repair.
Topics: Drug Combinations; Fasciotomy; Fibrinogen; Follow-Up Studies; Hernia, Inguinal; Herniorrhaphy; Humans; Postoperative Complications; Recurrence; Surgical Mesh; Thrombin; Treatment Outcome | 2013 |
Prognostic markers in young patients with premature coronary heart disease.
Topics: Adult; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Prognosis; Recurrence; Regression Analysis; Risk Factors; Survival Analysis; von Willebrand Factor | 2012 |
Renal transplantation in systemic amyloidosis-importance of amyloid fibril type and precursor protein abundance.
Topics: Adult; Amyloid; Amyloid beta-Protein Precursor; Amyloidosis; Apolipoprotein A-I; Biopsy; Databases, Factual; Female; Fibrinogen; Graft Survival; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Recurrence; Time Factors; Treatment Outcome; United Kingdom | 2013 |
Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome.
Topics: Adolescent; Adult; Aged; Atypical Hemolytic Uremic Syndrome; Biomarkers; Complement C3; Complement Factor B; Complement Factor H; Complement System Proteins; Female; Fibrinogen; Genetic Testing; Graft Rejection; Graft Survival; Hemolytic-Uremic Syndrome; Humans; Kidney Transplantation; Male; Membrane Cofactor Protein; Middle Aged; Mutation; Prognosis; Recurrence; Retrospective Studies; Risk Factors; Young Adult | 2013 |
[Inflammation study in unstable angina and myocardial infarction without ST segment elevation. Value of ultra-sensitive C-reactive protein].
Topics: Aged; Angina, Unstable; Biomarkers; C-Reactive Protein; Death, Sudden, Cardiac; Female; Fibrinogen; Follow-Up Studies; Hospitalization; Humans; Incidence; Inflammation; Leukocyte Count; Life Tables; Male; Middle Aged; Myocardial Infarction; Prognosis; Prospective Studies; Recurrence; Risk Factors; Sensitivity and Specificity | 2002 |
Balloon angioplasty in chronic critical limb ischemia: factors affecting clinical and angiographic outcome.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon; Chronic Disease; Female; Fibrinogen; Hemodynamics; Humans; Ischemia; Leg; Male; Middle Aged; Prognosis; Prospective Studies; Recurrence | 2002 |
Atherosclerosis and restenosis: an inflammatory issue.
Topics: Angioplasty, Balloon; Arteriosclerosis; Biomarkers; C-Reactive Protein; Fibrinogen; Humans; Inflammation; Recurrence; Serum Amyloid A Protein | 2002 |
Blood rheology in deep venous thrombosis--relation to persistent and transient risk factors.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Viscosity; Case-Control Studies; Erythrocyte Aggregation; Female; Fibrinogen; Follow-Up Studies; Hematologic Tests; Hemorheology; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Risk Factors; Time Factors; Venous Thrombosis | 2002 |
Preprocedural serum levels of acute-phase reactants and prognosis after percutaneous coronary intervention.
Topics: Acute-Phase Proteins; Aged; Angioplasty, Balloon, Coronary; Biomarkers; C-Reactive Protein; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Humans; Interleukin-6; Lipoprotein(a); Male; Middle Aged; Prognosis; Recurrence; Stents; Survival Rate | 2003 |
Elevated white cell count in acute coronary syndromes: relationship to variants in inflammatory and thrombotic genes.
Topics: Acute Disease; Angina, Unstable; Biomarkers; C-Reactive Protein; Clinical Trials as Topic; Coronary Thrombosis; Fibrinogen; Genetic Variation; Genotype; Humans; Inflammation; Interleukin 1 Receptor Antagonist Protein; Interleukin-6; Leukocyte Count; Myocardial Infarction; Polymorphism, Genetic; Recurrence; Risk Factors; Sialoglycoproteins; Syndrome | 2004 |
Pregnancy-related thrombosis in a woman with congenital afibrinogenemia: a report of two successful pregnancies.
Topics: Afibrinogenemia; Factor VIII; Female; Fibrinogen; Humans; Kidney; Ovary; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Complications, Hematologic; Pregnancy Outcome; Recurrence; Venous Thrombosis; von Willebrand Factor | 2004 |
Plasma thrombosis markers following cerebral infarction in African Americans.
Topics: Antithrombin III; Biomarkers; Black or African American; Cerebral Infarction; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Peptide Fragments; Peptide Hydrolases; Prothrombin; Recurrence; Thrombosis | 2005 |
[ACE inhibitor-induced angioedema in the head and neck region. A matter of time?].
Topics: Adult; Aged; Angioedema; Angiotensin-Converting Enzyme Inhibitors; C-Reactive Protein; Comorbidity; Drug Therapy, Combination; Female; Fibrinogen; Humans; Hypersensitivity; Male; Middle Aged; Muscle, Smooth, Vascular; Otorhinolaryngologic Diseases; Recurrence; Reference Values; Retrospective Studies; Risk Factors | 2004 |
Marked decrease in the levels of two inflammatory markers, hs-C-reactive protein and fibrinogen in patients with severe carotid atherosclerosis after eversion carotid endarterectomy.
Topics: Arteritis; C-Reactive Protein; Carotid Stenosis; Case-Control Studies; Endarterectomy, Carotid; Female; Fibrinogen; Humans; Male; Middle Aged; Recurrence; Time Factors | 2004 |
New cut-off values of cardiac markers for risk stratification of angina pectoris.
Topics: Aged; Angina Pectoris; Biomarkers; C-Reactive Protein; Creatine Kinase; Creatine Kinase, MB Form; Female; Fibrinogen; Humans; Isoenzymes; Male; Middle Aged; Prospective Studies; Recurrence; Risk Assessment; ROC Curve; Troponin I; Troponin T | 2005 |
Multimarker risk strategy for predicting 1-month and 1-year major events in non-ST-elevation acute coronary syndromes.
Topics: Aged; Analysis of Variance; Angina, Unstable; Biomarkers; C-Reactive Protein; Electrocardiography; Female; Fibrinogen; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myoglobin; Prognosis; Recurrence; Risk Assessment; Risk Factors; Troponin I | 2005 |
Fibrinogen as a predictor of mortality after acute myocardial infarction: a forty-two-month follow-up study.
Topics: Adult; Age Factors; Aged; Biomarkers; Blood Chemical Analysis; Cause of Death; Coronary Angiography; Fibrinogen; Follow-Up Studies; Humans; Intensive Care Units; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Predictive Value of Tests; Probability; Recurrence; Risk Assessment; Severity of Illness Index; Survival Analysis; Time Factors | 2005 |
Risk factors for cardiovascular event recurrence in the Atherosclerosis Risk in Communities (ARIC) study.
Topics: Atherosclerosis; Blood Pressure; Carotid Arteries; Cholesterol; Coronary Disease; Creatinine; Female; Fibrinogen; Follow-Up Studies; Humans; Hypertension; Leukocyte Count; Lipoprotein(a); Male; Middle Aged; Recurrence; Risk Factors; Serum Albumin; Smoking; Stroke; Tunica Intima; Tunica Media; Ultrasonography; Waist-Hip Ratio | 2005 |
Variation of inflammatory indexes after electrical cardioversion of persistent atrial fibrillation. Is there an association with early recurrence rates?
Topics: Aged; Analysis of Variance; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Echocardiography; Electric Countershock; Female; Fibrinogen; Humans; Leukocyte Count; Male; Prospective Studies; Recurrence | 2005 |
[Fibrinogen-guided thrombolysis with urokinase of a portal and mesenterial venous thrombosis during an acute episode of ulcerative colitis].
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Colitis, Ulcerative; Diarrhea; Drug Therapy, Combination; Female; Fibrinogen; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Heparin; Humans; Magnetic Resonance Imaging; Mesenteric Veins; Portal Vein; Prednisolone; Recurrence; Thrombolytic Therapy; Urokinase-Type Plasminogen Activator; Venous Thrombosis | 2006 |
Identification of plasma antifibrin/fibrinogen antibodies in a patient with hemolytic uremic syndrome.
Topics: ADAM Proteins; ADAMTS13 Protein; Adolescent; Antigen-Antibody Reactions; Autoantibodies; Blood Platelets; Female; Fibrin; Fibrinogen; Hemolytic-Uremic Syndrome; Humans; Immunoglobulin G; Platelet Aggregation; Recurrence; Renal Insufficiency; von Willebrand Factor | 2006 |
Late results of catheter-directed recombinant tissue plasminogen activator fibrinolytic therapy of iliofemoral deep venous thrombosis.
Topics: Acute Disease; Adolescent; Adult; Catheterization, Peripheral; Epidemiologic Methods; Female; Femoral Vein; Fibrinogen; Fibrinolytic Agents; Humans; Iliac Vein; Male; Middle Aged; Postphlebitic Syndrome; Recurrence; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Ultrasonography, Doppler, Duplex; Vascular Patency; Venous Thrombosis | 2007 |
The split abdominal wall muscle flap repair for large congenital diaphragmatic hernias on extracorporeal membrane oxygenation.
Topics: Abdominal Wall; Aminocaproates; Anticoagulants; Erythrocyte Transfusion; Extracorporeal Membrane Oxygenation; Factor VIII; Female; Fibrinogen; Hematocrit; Hernia, Diaphragmatic; Hernias, Diaphragmatic, Congenital; Humans; Infant, Newborn; Male; Plasma; Platelet Transfusion; Postoperative Complications; Postoperative Hemorrhage; Recurrence; Reoperation; Retrospective Studies; Surgical Flaps; Surgical Mesh | 2007 |
Laparoscopic transvesical repair of recurrent vesicovaginal fistula using with fleece-bound sealing system.
Topics: Adult; Drug Combinations; Female; Fibrinogen; Humans; Hysterectomy; Laparoscopy; Recurrence; Surgical Sponges; Thrombin; Vesicovaginal Fistula | 2008 |
[The effect of carotid stenting on rheological parameters, free radical production and platelet aggregation].
Topics: Aged; Carotid Stenosis; Clopidogrel; Female; Fibrinogen; Follow-Up Studies; Free Radicals; Hematocrit; Hemorheology; Humans; Male; Middle Aged; Oxidative Stress; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Recurrence; Risk Factors; Stents; Ticlopidine; Time Factors | 2007 |
Polymorphisms in coagulation factors and the risk of recurrent cardiovascular events in men after a first myocardial infarction.
Topics: Adult; Aged; Blood Coagulation Factors; Cardiovascular Diseases; Cohort Studies; DNA Mutational Analysis; Fibrinogen; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Recurrence; Risk Factors | 2008 |
Potential role of vasomotor effects of fibrinogen in bradykinin-induced angioedema.
Topics: Aged; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Cattle; Coronary Vessels; Female; Fibrinogen; Humans; Male; Middle Aged; Muscle, Smooth, Vascular; Organ Culture Techniques; Recurrence; Swine; Thoracic Arteries; Vasodilation; Vasodilator Agents | 2008 |
Acquired dysfibrinogenemia in a hemophiliac with hepatoma: resolution of fibrinogen dysfunction following chemotherapy.
Topics: Adolescent; Antineoplastic Agents; Blood Coagulation Disorders; Carcinoma, Hepatocellular; Fibrinogen; Hemophilia A; Hemophilia B; Humans; Liver Neoplasms; Male; Neoplasm Metastasis; Recurrence | 1981 |
[Injections of fibrin glue in severe epistaxis and Rendu-Osler disease].
Topics: Adult; Drug Combinations; Embolization, Therapeutic; Epistaxis; Factor XIII; Female; Fibrin Tissue Adhesive; Fibrinogen; Humans; Injections; Male; Middle Aged; Recurrence; Telangiectasia, Hereditary Hemorrhagic; Thrombin; Tissue Adhesives | 1984 |
[A suggestion concerning the technic of using fibrin glue in tympanoplasty].
Topics: Drug Combinations; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Humans; Postoperative Complications; Recurrence; Thrombin; Tissue Adhesives; Tympanoplasty; Wound Healing | 1984 |
[New treatment concept of tumor-caused chylothorax using fibrin glue. A clinical case report].
Topics: Adult; Chylothorax; Drug Combinations; Factor XIII; Female; Fibrin Tissue Adhesive; Fibrinogen; Hodgkin Disease; Humans; Ligation; Recurrence; Thoracic Duct; Thrombin; Tissue Adhesives | 1983 |
[Thoracoscopic pleurodesis in spontaneous pneumothorax].
Topics: Drug Combinations; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Humans; Pneumothorax; Recurrence; Thoracoscopy; Thrombin | 1983 |
Restoration of complement function in vivo by plasma infusion in factor I (C3b inactivator) deficiency.
Topics: Afibrinogenemia; Bacterial Infections; Blood Transfusion; Complement Pathway, Alternative; Complement Pathway, Classical; Complement System Proteins; Coombs Test; Female; Fibrinogen; Humans; Infant; Plasma; Recurrence | 1984 |
The diagnosis of acute recurrent deep-vein thrombosis.
Topics: Costs and Cost Analysis; Diagnosis, Differential; Fibrinogen; Humans; Iodine Radioisotopes; Plethysmography, Impedance; Radiography; Recurrence; Thrombophlebitis | 1984 |
Congenital hypofibrinogenemia and recurrent placental abruption.
Topics: Abruptio Placentae; Adult; Afibrinogenemia; Blood Coagulation Tests; Female; Fibrinogen; Humans; Pregnancy; Recurrence | 1983 |
Association of recurrent myocardial infarction with hemostatic factors: a prospective study.
Topics: Adult; Aged; Cholesterol; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Prospective Studies; Prothrombin; Prothrombin Time; Recurrence | 1982 |
Fibrinogen derivatives and recurrent myocardial infarction.
Topics: Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Myocardial Infarction; Prospective Studies; Recurrence; Risk | 1982 |
[Differential diagnosis of pneumonia and pulmonary tuberculosis recurrences].
Topics: Diagnosis, Differential; Fibrinogen; Humans; Male; Middle Aged; Pneumonia; Recurrence; Sialic Acids; Tuberculosis, Pulmonary | 1980 |
Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction.
Topics: Adenosine Diphosphate; beta-Thromboglobulin; Blood Platelets; Cell Adhesion Molecules; Fibrinogen; Flow Cytometry; Humans; Myocardial Infarction; P-Selectin; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Platelet Activation; Platelet Membrane Glycoproteins; Recombinant Proteins; Recurrence; Serotonin; Streptokinase; Thrombin; Thrombolytic Therapy; Thromboxane A2 | 1995 |
[Relation between plasma fibrinogen and the function of collateral coronary vessels].
Topics: Adult; Aged; Blood Viscosity; Cholesterol, LDL; Collateral Circulation; Coronary Circulation; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Recurrence; Reference Values; Risk Factors; Stroke Volume; Ventricular Function, Left | 1995 |
Evaluation of neopterin as a marker for restenosis following percutaneous transluminal coronary angioplasty.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Biomarkers; Biopterins; Chromatography, High Pressure Liquid; Coronary Angiography; Coronary Disease; Fibrinogen; Follow-Up Studies; Humans; Lipids; Male; Middle Aged; Neopterin; Recurrence | 1995 |
Fibrinogen after coronary angioplasty as a risk factor for restenosis.
Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Prospective Studies; Recurrence; Risk Factors; von Willebrand Factor | 1995 |
[Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
Topics: Aneurysm, Ruptured; Antithrombin III; Blood Coagulation Factors; Blood Coagulation Tests; Cerebral Hemorrhage; Factor XIII; Fibrin; Fibrinogen; Fibrinopeptide A; Hematoma, Subdural; Hemostasis, Surgical; Humans; Intracranial Aneurysm; Peptide Hydrolases; Plasminogen; Postoperative Complications; Protein C; Recurrence; Reference Values; Trephining | 1994 |
Characterization of local hyperfibrinolysis in chronic subdural hematomas by SDS-PAGE and immunoblot.
Topics: Adult; Aged; Aged, 80 and over; Blood Coagulation Disorders; Chronic Disease; Electrophoresis, Polyacrylamide Gel; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hematoma, Subdural; Humans; Immunoblotting; Male; Middle Aged; Recurrence; Sodium Dodecyl Sulfate | 1994 |
Tissue-type plasminogen activator and risk of myocardial infarction.
Topics: alpha-2-Antiplasmin; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Plasminogen Inactivators; Recurrence; Risk Factors; Tissue Plasminogen Activator | 1993 |
[Prevention of thrombosis in protein C deficiency].
Topics: Adolescent; Female; Fibrinogen; Heparin; Humans; Phenprocoumon; Phlebography; Protein C Deficiency; Prothrombin; Prothrombin Time; Recurrence; Thrombophlebitis | 1993 |
Fibrinogen and the albumin-globulin ratio in recurrent stroke.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Recurrence; Risk Factors; Serum Albumin; Serum Globulins; Vascular Diseases | 1993 |
The effect of prophylactic heparin treatment on enhanced thrombin generation in pregnancy.
Topics: Adult; Antithrombin III; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Humans; Partial Thromboplastin Time; Peptide Hydrolases; Platelet Count; Pregnancy; Pregnancy Complications, Hematologic; Protein C; Prothrombin; Puerperal Disorders; Recurrence; Thrombin; Thromboembolism | 1993 |
Physiologic benefits of a stress reduction program for healthy middle-aged Army officers.
Topics: Adult; Arousal; Behavior Therapy; Coronary Disease; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Fibrinogen; Humans; Hydrocortisone; Leukocyte Count; Life Style; Lipids; Male; Middle Aged; Military Personnel; Psychophysiologic Disorders; Recurrence; Stress, Psychological; Testosterone; Type A Personality | 1993 |
Long-term influence of fibrinogen on initial and recurrent cardiovascular events in men and women.
Topics: Age Factors; Aged; Cardiovascular Diseases; Cohort Studies; Female; Fibrinogen; Follow-Up Studies; Humans; Incidence; Male; Massachusetts; Middle Aged; Proportional Hazards Models; Recurrence; Risk Factors; Sex Factors; Time Factors | 1996 |
Influence of continued smoking and some biological risk factors on restenosis after percutaneous transluminal coronary angioplasty.
Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Endothelins; Epinephrine; Female; Fibrinogen; Humans; Linear Models; Lipids; Logistic Models; Male; Multivariate Analysis; Predictive Value of Tests; Prospective Studies; Recurrence; Risk Factors; Smoking; Tissue Plasminogen Activator | 1996 |
[Blood coagulation, genetics and post-angioplasty restenosis].
Topics: Angioplasty, Balloon, Coronary; Blood Coagulation; Disease Susceptibility; Factor Xa; Fibrinogen; Humans; Lipoprotein(a); Myocardial Ischemia; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Recurrence | 1997 |
Double treatment of severe hepatic veno-occlusive disease after allogeneic peripheral blood progenitor cell transplantation with recombinant tissue plasminogen activator.
Topics: Acute Kidney Injury; Female; Fibrinogen; Fibrinolytic Agents; Hematopoietic Stem Cell Transplantation; Heparin; Hepatic Veno-Occlusive Disease; Humans; Leukemia, Myelomonocytic, Acute; Male; Middle Aged; Recombinant Proteins; Recurrence; Thrombolytic Therapy; Tissue Plasminogen Activator; Transplantation Conditioning; Transplantation, Homologous | 1997 |
Restenosis after elective coronary balloon angioplasty in patients with end stage renal disease: a case-control study using quantitative coronary angiography.
Topics: Angioplasty, Balloon, Coronary; Case-Control Studies; Cholesterol; Cholesterol, HDL; Coronary Angiography; Coronary Disease; Fibrinogen; Humans; Kidney Failure, Chronic; Male; Middle Aged; Recurrence; Retrospective Studies; Triglycerides | 1997 |
Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty.
Topics: Angioplasty, Balloon; Antithrombin III; Arterial Occlusive Diseases; Biomarkers; Blood Coagulation Tests; C-Reactive Protein; Cardiovascular Diseases; Comorbidity; Creatinine; Diabetes Mellitus; Female; Femoral Artery; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hyperlipidemias; Lipids; Male; Metabolic Clearance Rate; Peptide Fragments; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Popliteal Artery; Prospective Studies; Prothrombin; Recurrence; Risk; Risk Factors; Smoking; Thrombin; Thrombophilia; Tissue Plasminogen Activator; Treatment Failure; Ultrasonography, Doppler, Color; von Willebrand Factor | 1997 |
Haemostatic and rheological factors as predictors of restenosis following percutaneous transluminal angioplasty.
Topics: Angioplasty, Balloon; Arteriosclerosis; Blood Viscosity; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematocrit; Hemorheology; Hemostasis; Humans; Leg; Male; Plasminogen Activator Inhibitor 1; Prospective Studies; Recurrence; von Willebrand Factor | 1997 |
Selective alpha v beta 3 integrin blockade potently limits neointimal hyperplasia and lumen stenosis following deep coronary arterial stent injury: evidence for the functional importance of integrin alpha v beta 3 and osteopontin expression during neointi
Topics: Animals; Cell Adhesion; Cell Movement; Coronary Disease; Coronary Vessels; Endothelium, Vascular; Fibrinogen; Osteopontin; Peptides, Cyclic; Protein Binding; Receptors, Vitronectin; Recurrence; Sialoglycoproteins; Stents; Swine; Vitronectin | 1997 |
Persistent inflammatory response in stroke survivors.
Topics: Acute-Phase Proteins; Acute-Phase Reaction; Aged; Cerebrovascular Disorders; Female; Fibrinogen; Humans; Inflammation; Longitudinal Studies; Male; Middle Aged; Recurrence; Reference Values; Risk Factors | 1998 |
Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability.
Topics: Aged; Angina, Unstable; C-Reactive Protein; Chlamydophila pneumoniae; Cholesterol; Female; Fibrinogen; Follow-Up Studies; Hospitalization; Humans; Male; Middle Aged; Prognosis; Recurrence | 1999 |
Recurrent and persistent coagulopathy following pit viper envenomation.
Topics: Adolescent; Adult; Aged; Animals; Antivenins; Blood Coagulation Disorders; Child; Chronic Disease; Crotalid Venoms; Fibrinogen; Humans; Immunoglobulin Fab Fragments; Middle Aged; Partial Thromboplastin Time; Platelet Count; Prothrombin Time; Recurrence; Snake Bites; Time Factors; Viper Venoms; Viperidae | 1999 |
Thrombogenic factors and recurrent coronary events.
Topics: Adult; Aged; Factor VII; Factor VIIa; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Insulin; Lipids; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Prospective Studies; Recurrence; Risk Factors; Thrombosis; von Willebrand Factor | 1999 |
Changes of hemostasis, endogenous fibrinolysis, platelet activation and endothelins after percutaneous transluminal coronary angioplasty in patients with stable angina.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Anticoagulants; Antithrombin III; beta-Thromboglobulin; Coronary Angiography; Endothelins; Fibrinogen; Fibrinolysis; Hemostasis; Heparin; Humans; Male; Middle Aged; Peptide Fragments; Peptide Hydrolases; Platelet Activation; Prothrombin; Recurrence; Treatment Failure | 1999 |
Platelet activation as a potential mechanism of GP IIb/IIIa inhibitor-induced thrombocytopenia.
Topics: Abciximab; Adult; Aged; Antibodies, Monoclonal; Drug Therapy, Combination; Dual Specificity Phosphatase 2; Female; Fibrinogen; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Phosphatase 2; Protein Tyrosine Phosphatases; Recombinant Proteins; Recurrence; Thrombocytopenia; Thrombolytic Therapy; Tissue Plasminogen Activator | 1999 |
Plasma fibrinogen as a risk factor for restenosis after percutaneous transluminal renal angioplasty in patients with atherosclerotic renal artery stenosis.
Topics: Angiography; Angioplasty, Balloon; Arteriosclerosis; Biomarkers; Confidence Intervals; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Odds Ratio; Prospective Studies; Recurrence; Renal Artery Obstruction; Risk Factors; Ultrasonography, Doppler, Duplex | 1999 |
Recurrent spontaneous intracerebral hemorrhage in a congenitally afibrinogenemic patient: diagnostic pitfalls and therapeutic options.
Topics: Afibrinogenemia; Cerebral Hemorrhage; Factor VIII; Female; Fibrinogen; Fibronectins; Follow-Up Studies; Hemostatics; Humans; Magnetic Resonance Imaging; Paresis; Pulmonary Embolism; Recurrence; Tomography, X-Ray Computed | 1999 |
Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty.
Topics: Aged; Angioplasty, Balloon, Coronary; C-Reactive Protein; Female; Fibrinogen; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Recurrence; Risk Assessment; Serum Amyloid A Protein | 1999 |
Elevated high molecular weight fibrinogen in plasma is predictive of coronary ischemic events after acute myocardial infarction.
Topics: Aged; Biomarkers; Convalescence; Coronary Thrombosis; Female; Fibrin; Fibrinogen; Fibrinopeptide A; Follow-Up Studies; Humans; Male; Middle Aged; Molecular Weight; Myocardial Infarction; Phosphorus; Phosphorylation; Protein Processing, Post-Translational; Recurrence | 1999 |
Analysis of prothrombotic effects of two human monoclonal IgG antiphospholipid antibodies of apparently similar specificity.
Topics: Adenosine Diphosphate; Animals; Antibodies, Antiphospholipid; Antibodies, Monoclonal; Antibody Specificity; Antiphospholipid Syndrome; Autoimmune Diseases; Biomarkers; Blood Coagulation Factors; Blood Platelets; Cattle; Cells, Cultured; Dose-Response Relationship, Immunologic; Endothelium, Vascular; Female; Fibrinogen; Humans; Immunoglobulin G; Intracranial Embolism; Lipopolysaccharides; Lupus Erythematosus, Systemic; Male; Middle Aged; Monocytes; Peptide Fragments; Platelet Activation; Recurrence; Thrombophilia; Thromboplastin | 2000 |
Decreased tissue factor and tissue-plasminogen activator antigen in relapsed acute promyelocytic leukemia.
Topics: Adolescent; Adult; Antigens; Female; Fibrinogen; Hemostasis; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Recurrence; Thromboplastin; Tissue Plasminogen Activator | 2000 |
[Activation of coagulation cascade in children during an idiopathic nephrotic syndrome relapse].
Topics: Adolescent; Biomarkers; Blood Coagulation Factors; Child; Child, Preschool; Female; Fibrinogen; Humans; Male; Nephrotic Syndrome; Recurrence | 2000 |
The incidence of thrombovenous and thromboembolic complications in kidney transplant patients with recurrent glomerulonephritis is dependent on the occurrence of severe proteinuria.
Topics: Adult; Antithrombins; Female; Fibrinogen; Glomerulonephritis; Humans; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Proteinuria; Recurrence; Thromboembolism; Thrombosis; Transplantation, Homologous | 2000 |
Clinical application of procedural platelet monitoring during percutaneous coronary intervention among patients at increased bleeding risk.
Topics: Abciximab; Adult; Aged; Aged, 80 and over; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Carotid Stenosis; Clopidogrel; Comorbidity; Coronary Artery Bypass; Drug Therapy, Combination; Female; Fibrinogen; Graft Occlusion, Vascular; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Microspheres; Peptide Fragments; Platelet Aggregation Inhibitors; Platelet Count; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Recurrence; Risk; Stents; Ticlopidine | 2001 |
Biological profiles in subjects with recurrent acute coronary events compared with subjects with long-standing stable angina.
Topics: Angina Pectoris; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Follow-Up Studies; Homocysteine; Humans; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Recurrence; Tissue Plasminogen Activator; von Willebrand Factor | 2001 |
Restenosis after percutaneous transluminal angioplasty in the femoropopliteal segment: the role of inflammation.
Topics: Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; C-Reactive Protein; Cohort Studies; Constriction, Pathologic; Female; Femoral Artery; Fibrinogen; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Popliteal Artery; Postoperative Complications; Predictive Value of Tests; Recurrence; Retrospective Studies; Time Factors; Vascular Patency | 2001 |
Relationship between fibrinogen protein and fibrinogen function in postmyocardial infarction patients.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Case-Control Studies; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; N-Acetylneuraminic Acid; Recurrence; Retrospective Studies; Thrombophilia | 2001 |
Hyperfibrinogenemia increases the risk of cardiac events after coronary artery stenting.
Topics: Aged; Angioplasty, Balloon, Coronary; Cholesterol; Coronary Angiography; Coronary Artery Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Recurrence; Risk Factors; Stents; Thrombosis | 2000 |
Prediction of stroke in the general population in Europe (EUROSTROKE): Is there a role for fibrinogen and electrocardiography?
Topics: Adult; Age Factors; Aged; Case-Control Studies; Databases, Factual; Electrocardiography; Europe; Female; Fibrinogen; Humans; Logistic Models; Male; Middle Aged; Multicenter Studies as Topic; Predictive Value of Tests; Recurrence; Risk Factors; Stroke | 2002 |
Reduced inhibition of activated prothrombin by heparin and venous thromboembolism: heparin resistance revisited.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Antithrombin III; Blood Coagulation Tests; Child; Drug Resistance; Female; Fibrinogen; Heparin; Humans; Male; Middle Aged; Prothrombin; Recurrence; Risk Factors; Thrombophilia; Venous Thrombosis | 2002 |
[Acute phase proteins and recurrence of angina after effective coronary angioplasty].
Topics: Acute-Phase Proteins; Adult; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Biomarkers; C-Reactive Protein; Coronary Restenosis; Factor Analysis, Statistical; Female; Fibrinogen; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Predictive Value of Tests; Recurrence; Risk Factors | 2002 |
Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients.
Topics: Aged; Anticoagulants; Biomarkers; Brain; Brain Ischemia; C-Reactive Protein; Cardiovascular Diseases; Comorbidity; Disease-Free Survival; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Humans; Inflammation; Magnetic Resonance Imaging; Male; Multivariate Analysis; Platelet Aggregation Inhibitors; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Recurrence; Risk Assessment; Stroke; Time; Tomography, X-Ray Computed; Treatment Outcome | 2002 |
[Experimental studies on fibrinolytic activity and angiospasm following subarachnoid hemorrhage in dogs (author's transl)].
Topics: Animals; Dogs; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Intracranial Aneurysm; Ischemic Attack, Transient; Recurrence; Subarachnoid Hemorrhage | 1978 |
[Closure of recurrent perforations of the tympanic membrane (author's transl)].
Topics: Fibrin; Fibrinogen; Humans; Recurrence; Thrombin; Tissue Adhesives; Tympanic Membrane | 1979 |
Problems of resistant thrombolysis and early recurrent thrombosis in streptokinase therapy.
Topics: Anticoagulants; Femoral Vein; Fibrinogen; Fibrinolysis; Humans; Iliac Vein; Plasminogen; Recurrence; Streptokinase; Thromboembolism; Thrombophlebitis; Thrombosis | 1978 |
The importance of plasma lipid, glucose, insulin and fibrinogen in femoropopliteal surgery.
Topics: Adult; Aged; Arterial Occlusive Diseases; Blood Glucose; Female; Femoral Artery; Fibrinogen; Follow-Up Studies; Humans; Insulin; Lipids; Male; Middle Aged; Popliteal Artery; Recurrence | 1978 |
Plasma fibrinopeptide A levels in symptomatic venous thromboembolism.
Topics: Adult; Aged; Fibrinogen; Fibrinopeptide A; Heparin; Humans; Lung; Middle Aged; Radionuclide Imaging; Recurrence; Thromboembolism; Thromboplastin; Time Factors | 1978 |
Recurrent venous thrombosis.
Topics: Fibrinogen; Humans; Radionuclide Imaging; Recurrence; Thrombophlebitis | 1978 |
[Survival and state of patients during the 1st year after myocardial infarct (according to data of epidemiological study - myocardial infarct register)].
Topics: Adult; Aged; Angina Pectoris; Blood Coagulation Disorders; Blood Glucose; Cholesterol; Fibrinogen; Follow-Up Studies; Heart Failure; Humans; Middle Aged; Myocardial Infarction; Prognosis; Recurrence; Thrombelastography; Thromboembolism; Time Factors | 1975 |
[Recurring retinal haemorrhages with tortuosity of the retinal arteriols (author's transl)].
Topics: Adult; Blood Cell Count; Female; Fibrinogen; Fluorescein Angiography; Humans; Male; Recurrence; Retinal Artery; Retinal Diseases; Retinal Hemorrhage; Syndrome; Thrombelastography; Vascular Diseases | 1975 |
[Pathochemical changes in pseudotuberculosis].
Topics: Acute Disease; Autoantibodies; Complement Fixation Tests; Fibrinogen; Humans; Recurrence; Sarcoidosis; Time Factors | 1975 |
Venous disease. Advances in objective diagnosis.
Topics: Fibrinogen; Humans; Iodine Radioisotopes; Methods; Phlebography; Plethysmography; Recurrence; Thrombophlebitis; Ultrasonography; Varicose Veins | 1976 |
Partial characterization of an autoantibody recognizing the secondary binding site(s) of thrombin in a patient with recurrent spontaneous arterial thrombosis.
Topics: Adult; Antithrombin III; Arteries; Autoantibodies; Binding Sites, Antibody; Female; Fibrinogen; Heparin Cofactor II; Humans; Protein Binding; Receptors, Cell Surface; Receptors, Thrombin; Recurrence; Thrombin; Thrombin Time; Thrombosis | 1992 |
Vampire bat salivary plasminogen activator promotes rapid and sustained reperfusion without concomitant systemic plasminogen activation in a canine model of arterial thrombosis.
Topics: alpha-Macroglobulins; Animals; Arterial Occlusive Diseases; Chiroptera; Dogs; Enzymes; Female; Femoral Artery; Fibrin; Fibrinogen; Fibrinolysin; Male; Plasminogen; Plasminogen Activators; Recurrence; Reperfusion; Salivary Glands; Thrombosis; Tissue Plasminogen Activator | 1992 |
Fibrinogen values in patients with and without restenosis following percutaneous transluminal coronary angiography.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Recurrence; Risk Factors | 1992 |
Effectiveness and safety of a single intravenous bolus injection of tissue-type plasminogen activator in acute myocardial infarction. Bolus Dose-Escalation Study of Tissue-Type Plasminogen Activator (BEST) Investigators.
Topics: Adult; Aged; Electrocardiography; Female; Fibrinogen; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Recurrence; Thrombolytic Therapy; Tissue Plasminogen Activator; Vascular Patency | 1992 |
Smoking and factors influencing the outcome of arterial reconstruction.
Topics: Aged; Blood Vessel Prosthesis; Carboxyhemoglobin; Cholesterol; Female; Fibrinogen; Graft Occlusion, Vascular; Humans; Ischemia; Leg; Male; Middle Aged; Patient Compliance; Postoperative Complications; Recurrence; Reoperation; Risk Factors; Smoking; Thiocyanates; Veins | 1992 |
Stanozolol in treatment of leg ulcers due to cryofibrinogenaemia.
Topics: Adult; Aged; Cryoglobulinemia; Cryoglobulins; Female; Fibrinogen; Fibrinogens, Abnormal; Humans; Leg Ulcer; Male; Middle Aged; Recurrence; Stanozolol | 1991 |
Effect of recombinant hirudin (LU 52369) on reocclusion rates after thrombolysis in rabbits.
Topics: alpha-2-Antiplasmin; Animals; Drug Synergism; Drug Therapy, Combination; Fibrinogen; Fibrinolytic Agents; Hirudin Therapy; Iliac Artery; Rabbits; Recombinant Proteins; Recurrence; Thrombin; Thrombolytic Therapy; Thrombosis | 1991 |
Purpura and recurrent ulcers on the lower extremities. Essential cryofibrinogenemia.
Topics: Adult; Cryoglobulinemia; Cryoglobulins; Fibrinogen; Fibrinogens, Abnormal; Humans; Leg Ulcer; Male; Purpura; Recurrence | 1991 |
The effect of desmopressin on massive gastrointestinal bleeding in hereditary telangiectasia unresponsive to treatment with cryoprecipitate.
Topics: Adult; Deamino Arginine Vasopressin; Factor VIII; Fibrinogen; Gastrointestinal Hemorrhage; Humans; Male; Recurrence; Telangiectasia, Hereditary Hemorrhagic | 1990 |
Correlations between fibrinolytic function and acute myocardial infarction.
Topics: Adult; Case-Control Studies; Fibrinogen; Fibrinolysis; Follow-Up Studies; Humans; Male; Myocardial Infarction; Plasminogen Inactivators; Prospective Studies; Recurrence; Tissue Plasminogen Activator | 1990 |
Prognostic significance of fibrinopeptide A in survivors of cerebral infarction.
Topics: beta-Thromboglobulin; Cerebral Infarction; Fibrinogen; Fibrinopeptide A; Humans; Osmolar Concentration; Prognosis; Recurrence; Survival | 1990 |
Haemostatic abnormalities and outcome in patients with operable breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Fibrinopeptide B; Hemostasis; Humans; Middle Aged; Peptide Fragments; Predictive Value of Tests; Prognosis; Recurrence; Time Factors | 1990 |
[Blood coagulation disorders in intracerebral hematoma caused by rupture of intracranial angioma. Incidences on hemorrhagic recurrence].
Topics: Adolescent; Adult; Aged; Blood Coagulation Disorders; Blood Coagulation Tests; Brain Neoplasms; Cerebral Hemorrhage; Child; Female; Fibrinogen; Hemangioma; Hematoma; Humans; Intracranial Arteriovenous Malformations; Male; Middle Aged; Platelet Count; Recurrence; Rupture, Spontaneous | 1990 |
Hypercoagulable state after thrombolytic therapy in patients with acute myocardial infarction (AMI) treated with streptokinase.
Topics: Adult; Aged; Blood Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Recurrence; Streptokinase; Thrombin | 1990 |
Prevention of thrombosis and rethrombosis. New approaches.
Topics: Animals; Antithrombins; Cardiology; Fibrinogen; Humans; Platelet Aggregation Inhibitors; Protein C; Recombinant Proteins; Recurrence; Thrombosis; Thromboxane A2 | 1990 |
[Clinical experiences with systemic high-dosage short-term fibrinolysis in acute myocardial infarct].
Topics: Adult; Aged; Cardiac Complexes, Premature; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Female; Fibrinogen; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Recurrence; Streptokinase; Thrombin Time | 1986 |
[Treatment of testicular hydroceles with puncture and injection of fibrin glue (Tisseel)].
Topics: Adult; Aged; Aprotinin; Drug Combinations; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Humans; Male; Middle Aged; Punctures; Recurrence; Suction; Testicular Diseases; Testicular Hydrocele; Thrombin | 1986 |
[Occlusion therapy in chronic recurrent parotitis? A report of clinical experiences with the use of a fibrin glue-gentamycin mixture].
Topics: Aprotinin; Chronic Disease; Drug Combinations; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Follow-Up Studies; Gentamicins; Humans; Injections; Methylmethacrylates; Parotid Gland; Parotitis; Recurrence; Thrombin | 1988 |
[Fibrin gluing in spontaneous pneumothorax].
Topics: Adult; Aprotinin; Drug Combinations; Factor XIII; Female; Fibrin Tissue Adhesive; Fibrinogen; Humans; Pneumothorax; Pulmonary Emphysema; Recurrence; Thoracoscopes; Thrombin | 1989 |
Low dose urokinase preactivated natural prourokinase for thrombolysis in acute myocardial infarction.
Topics: Aged; Coronary Angiography; Drug Therapy, Combination; Enzyme Activation; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Plasminogen Activators; Prospective Studies; Recurrence; Urokinase-Type Plasminogen Activator; Vascular Patency | 1989 |
The thrombolytic effects of native tissue-type plasminogen activator (AK-124) on experimental canine coronary thrombosis.
Topics: Animals; Coronary Disease; Coronary Thrombosis; Dogs; Fibrin; Fibrinogen; Humans; Platelet Aggregation; Recurrence; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 1989 |
Monitoring of fibrin generation during thrombolytic therapy of acute myocardial infarction with recombinant tissue-type plasminogen activator.
Topics: Coronary Angiography; Female; Fibrin; Fibrinogen; Fibrinopeptide A; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Radioimmunoassay; Recombinant Proteins; Recurrence; Time Factors; Tissue Plasminogen Activator | 1989 |
A new thrombolytic regimen for acute myocardial infarction using combination half dose tissue-type plasminogen activator with full dose streptokinase: a pilot study. KAMIT Study Group.
Topics: Aged; Coronary Angiography; Drug Therapy, Combination; Female; Fibrinogen; Hemorrhage; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Pilot Projects; Recurrence; Streptokinase; Stroke Volume; Tissue Plasminogen Activator; Vascular Patency | 1989 |
Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator.
Topics: Adult; Aged; Coronary Angiography; Electrocardiography; Female; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Recombinant Proteins; Recurrence; Tissue Plasminogen Activator; Vascular Patency | 1989 |
Femoral artery recanalisation with percutaneous angioplasty and segmentally enclosed plasminogen activator.
Topics: Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; Catheters, Indwelling; Combined Modality Therapy; Femoral Artery; Fibrinogen; Heparin; Humans; Middle Aged; Plasminogen Activators; Recombinant Proteins; Recurrence; Thrombosis; Time Factors; Vascular Patency | 1989 |
[Exploratory strategy in venous thromboembolic disease].
Topics: Doppler Effect; Fibrinogen; Humans; Phlebography; Plethysmography, Impedance; Recurrence; Thromboembolism; Ultrasonography | 1989 |
[Three case reports of relapsing polychondritis and their immunopathological analysis].
Topics: Aged; Autoimmune Diseases; Cartilage; Complement C3; Complement C4; Fibrinogen; Humans; Immunoglobulin G; Male; Middle Aged; Osteochondritis; Recurrence | 1989 |
Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.
Topics: Adult; Fibrinogen; Follow-Up Studies; Glycoproteins; Hemostasis; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Male; Methods; Middle Aged; Myocardial Infarction; Plasminogen Activators; Plasminogen Inactivators; Prospective Studies; Recurrence; Risk; Triglycerides | 1987 |
[Intravenous thrombolysis in myocardial infarction. Influence of the quality of the anticoagulation on the early recurrence rate of angina or infarction].
Topics: Adult; Aged; Anticoagulants; Coronary Angiography; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Recurrence; Retrospective Studies; Streptokinase | 1988 |
Preventive effects of batroxobin on experimental canine coronary thrombosis.
Topics: Animals; Aspirin; Batroxobin; Coronary Disease; Coronary Thrombosis; Disease Models, Animal; Dogs; Electrocardiography; Fibrinogen; Hemodynamics; Heparin; Recurrence; Serine Endopeptidases; Urokinase-Type Plasminogen Activator | 1988 |
Cryofibrinogenemic purpura.
Topics: Cryoglobulinemia; Cryoglobulins; Fibrinogen; Fibrinogens, Abnormal; Humans; Immunoenzyme Techniques; Lectins; Male; Microscopy, Fluorescence; Middle Aged; Plant Lectins; Purpura; Recurrence | 1987 |
Clinical effects and kinetic properties of intravenous APSAC--anisoylated plasminogen-streptokinase activator complex (BRL 26921) in acute myocardial infarction.
Topics: Adult; Aged; Anistreplase; Fibrinogen; Follow-Up Studies; Half-Life; Heart; Hemostasis; Humans; Infusions, Parenteral; Kinetics; Middle Aged; Myocardial Infarction; Plasminogen; Recurrence; Streptokinase; Time Factors | 1986 |
[Recurrent exanthema in cryofibrinogenemia].
Topics: Cold Temperature; Cryoglobulinemia; Cryoglobulins; Exanthema; Fibrinogen; Fibrinogens, Abnormal; Humans; Male; Middle Aged; Recurrence; Skin | 1987 |
[Use of fibrin glue in pronounced Dupuytren contracture].
Topics: Drug Combinations; Dupuytren Contracture; Factor XIII; Fasciotomy; Fibrin Tissue Adhesive; Fibrinogen; Hand Deformities, Acquired; Hematoma; Humans; Postoperative Complications; Recurrence; Tendons; Thrombin; Wound Healing | 1985 |
[Use of human fibrin glue in the closure of vesicovaginal fistulas].
Topics: Animals; Cicatrix; Drug Combinations; Factor XIII; Female; Fibrin Tissue Adhesive; Fibrinogen; Rabbits; Recurrence; Thrombin; Tissue Adhesives; Urinary Bladder; Vagina; Vesicovaginal Fistula; Wound Healing | 1985 |
[Experience with fibrin glue in type-III tympanoplasty with stapes elevation].
Topics: Audiometry; Chronic Disease; Drug Combinations; Drug Evaluation; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Humans; Otitis Media; Postoperative Complications; Recurrence; Retrospective Studies; Stapes Mobilization; Thrombin; Time Factors; Tissue Adhesives; Tympanoplasty | 1985 |
Bypass surgery following thrombolytic therapy.
Topics: Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Coronary Artery Bypass; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Middle Aged; Myocardial Infarction; Recurrence; Risk | 1985 |
Tissucol in closure of oroantral communication. A pilot study.
Topics: Adult; Drug Combinations; Factor XIII; Female; Fibrin Tissue Adhesive; Fibrinogen; Fibronectins; Humans; Male; Middle Aged; Oroantral Fistula; Pilot Projects; Recurrence; Thrombin; Tissue Adhesives; Wound Healing | 1985 |
Hemorrhage vs rethrombosis after thrombolysis for acute myocardial infarction.
Topics: Coronary Disease; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Humans; Infusions, Intra-Arterial; Myocardial Infarction; Recurrence; Streptokinase | 1986 |
Effect of anticoagulation on the lysis of filter entrapped thromboembolism in dogs.
Topics: Administration, Oral; Animals; Anticoagulants; Dogs; Female; Fibrinogen; Filtration; Heparin; Leukocyte Count; Male; Partial Thromboplastin Time; Platelet Count; Prothrombin Time; Recurrence; Thromboembolism; Warfarin | 1985 |
Fibrinogen Irvine: a qualitatively abnormal fibrinogen associated with the predisposition to recurrent visceral and peripheral venous thrombosis.
Topics: Adult; Blood Coagulation Disorders; Fibrinogen; Fibrinogens, Abnormal; Humans; Male; Pedigree; Recurrence; Thrombophlebitis | 1985 |
Phenformin plus ethyloestrenol in survivors of myocardial infarction. Three-year pilot study.
Topics: Adult; Age Factors; Blood Platelets; Cholesterol; Drug Synergism; Ethylestrenol; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Phenformin; Potassium; Recurrence; Time Factors | 1972 |
The effect of phenformin plus stanozolol on fibrinolysis, platelet adhesiveness and blood lipids in patients with recurrent venous thrombosis.
Topics: Adult; Aged; Cholesterol; Drug Therapy, Combination; Edetic Acid; Female; Fibrinogen; Fibrinolysis; Humans; Lipids; Lipoproteins; Male; Middle Aged; Phenformin; Platelet Adhesiveness; Recurrence; Serum Globulins; Stanozolol; Thrombophlebitis | 1974 |
Early and intensive therapy of intravascular coagulation in acute liver failure.
Topics: Acute Disease; Adult; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Disseminated Intravascular Coagulation; Female; Fibrinogen; Heparin; Hepatic Encephalopathy; Humans; Infusions, Parenteral; Iodine Radioisotopes; Liver Function Tests; Male; Middle Aged; Plasma; Prothrombin Time; Recurrence; Time Factors | 1971 |
A prospective comparison of four methods for the diagnosis of deep vein thrombosis.
Topics: Acute Disease; Adolescent; Adult; Aged; Female; Fibrinogen; Humans; Iodine Radioisotopes; Leg; Male; Middle Aged; Phlebography; Plethysmography, Impedance; Prospective Studies; Recurrence; Thrombophlebitis; Ultrasonography | 1974 |
Newer ways to prevent pulmonary embolism.
Topics: Fibrinogen; Heparin; Humans; Immobilization; Iodine Radioisotopes; Platelet Adhesiveness; Pulmonary Embolism; Radionuclide Imaging; Recurrence; Snake Venoms; Thrombophlebitis | 1974 |
Serosal hypofibrinolysis. A cause of postoperative adhesions.
Topics: Animals; Blood Coagulation Tests; Blood Platelets; Colon; Dogs; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hematocrit; Ileum; Omentum; Peritoneum; Postoperative Complications; Recurrence; Stomach; Tissue Adhesions; Wound Healing | 1973 |
Streptokinase therapy in deep-vein thrombosis.
Topics: Adult; Aged; Blood Coagulation Tests; Catheterization; Female; Femoral Vein; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Iliac Vein; Injections, Intravenous; Male; Middle Aged; Phlebography; Postoperative Complications; Recurrence; Streptokinase; Thrombophlebitis; Time Factors | 1973 |
The use of antifibrinolytic drugs to prevent early recurrent aneurysmal subarachnoid haemorrhage.
Topics: Adult; Aged; Antifibrinolytic Agents; Blood Cell Count; Cerebral Angiography; Cyclohexanecarboxylic Acids; Factor IX; Factor V; Factor VII; Factor X; Female; Fibrin; Fibrinogen; Fibrinolytic Agents; Humans; Hydralazine; Intracranial Aneurysm; Male; Methyldopa; Middle Aged; Phenytoin; Prothrombin; Recurrence; Subarachnoid Hemorrhage | 1973 |
Thrombolytic therapy with streptokinase: a retrospective study.
Topics: Antibody Formation; Blood Coagulation Tests; Dose-Response Relationship, Drug; Fibrinogen; Humans; Plasminogen; Recurrence; Retrospective Studies; Streptokinase; Thrombophlebitis; Thrombosis; Time Factors | 1973 |
Laboratory control of SK therapy.
Topics: Acute Disease; Arterial Occlusive Diseases; Blood Coagulation; Blood Coagulation Tests; Chronic Disease; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Humans; Peptide Hydrolases; Plasminogen; Recurrence; Serum Globulins; Snake Venoms; Solubility; Streptokinase; Thrombelastography; Thrombin; Time Factors | 1973 |
Coagulation and platelet adhesiveness in recurrent "idiopathic" venous thrombosis.
Topics: Adult; Aged; Blood Cell Count; Blood Coagulation; Blood Coagulation Tests; Factor V; Factor VIII; Fibrinogen; Humans; Middle Aged; Phlebography; Platelet Adhesiveness; Prothrombin Time; Recurrence; Thrombophlebitis | 1972 |
Recurrent venous thrombosis and portal hypertension.
Topics: Adult; Blood Protein Disorders; Cold Temperature; Fibrinogen; Humans; Hypertension, Portal; Male; Recurrence; Syndrome; Thrombophlebitis; Thrombosis | 1972 |
[Fibrinogen level in chronic-recurring urticaria].
Topics: Adolescent; Adult; Afibrinogenemia; Child; Chronic Disease; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Recurrence; Urticaria | 1970 |